<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Pathology-2) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">60</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 65183,
    "choices": [
      {
        "id": 259909,
        "text": "<p><span style=\"font-size:12.0pt;\">1 Fc and 2 Fab fragments</span></p>"
      },
      {
        "id": 259910,
        "text": "<p><span style=\"font-size:12.0pt;\">1 F(ab')\u2082 and a degraded Fc fragment</span></p>"
      },
      {
        "id": 259911,
        "text": "<p><span style=\"font-size:12.0pt;\">1 Variable chain and 1 constant chain</span></p>"
      },
      {
        "id": 259912,
        "text": "<p><span style=\"font-size:12.0pt;\">2 Fc and 2 Fab fragments</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">When pepsin acts on a molecule of immunoglobulin, which of the following are the end products? (Twisted PYQ)</span></p>",
    "unique_key": "Q4142503",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578741,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1 F(ab')\u2082 and a degraded Fc fragment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When pepsin acts on an immunoglobulin molecule, it cleaves below the disulfide bonds in the hinge region of the heavy chains. This results in the formation of one F(ab')\u2082 fragment, which contains both antigen-binding sites connected by disulfide bonds, and a degraded Fc fragment composed of smaller peptides.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pepsin digestion differs from papain digestion, which cleaves above the disulfide bonds and produces two Fab fragments and one Fc fragment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1_djtemrC.jpg\" width=\"1307\" height=\"619\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1 Fc and 2 Fab fragments</strong>: Incorrect. This is the result of digestion with papain, not pepsin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 1 Variable chain and 1 constant chain</strong>: Incorrect. This is not the result of enzymatic cleavage by either papain or pepsin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2 Fc and 2 Fab fragments</strong>: Incorrect. Such fragmentation is not observed with enzymatic digestion of immunoglobulins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1_a1twXxs.jpg\" width=\"1307\" height=\"619\"></strong></span></p>",
    "correct_choice_id": 259910,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10319,
    "choices": [
      {
        "id": 41242,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herpes-simplex virus</span></span></span></p>"
      },
      {
        "id": 41243,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cytomegalovirus</span></span></span></p>"
      },
      {
        "id": 41244,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida</span></span></span></p>"
      },
      {
        "id": 41245,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Punched-out ulcers in the esophagus are caused by: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q1014123",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578770,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Herpes-simplex virus </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infection with the Herpes simplex virus (HS) causes <strong>punched-out ulcers in the esophagus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunocompromised patients are more likely to develop HS esophagitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endoscopic findings may include multiple discrete or coalescent small ulcers that appear superficial, punched out, or volcano-like.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/5_aYMBZut.jpg\" style=\"height:234px; width:329px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For diagnosis, the biopsy sample should be taken from the edge of the ulcer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The following microscopic findings are seen here:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ballooning degeneration</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ground-glass changes in nuclei</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infected squamous epithelial cells show<strong> 3 M&rsquo;</strong>s:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">olding of nuclear contours</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">argination of chromatin to the periphery of nuclei</span></span></span></li>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ultinucleation </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intranuclear inclusions:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cowdry type A:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> acidophilic inclusion with surrounding clear halo </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Equivocal cases require an HSV immunohistochemical (IHC) stain to confirm the diagnosis</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-124341.png\" style=\"height:223px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cytomegalovirus (CMV)</span></strong><span style=\"font-size:12.0pt\">: Causes larger, shallow ulcers and might involve deeper tissue layers, with &quot;owl&#39;s eye&quot; inclusions typically seen.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Candida</span></strong><span style=\"font-size:12.0pt\">: Presents typically as white plaques or linear fissures rather than punched-out ulcers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acid</span></strong><span style=\"font-size:12.0pt\">: Causes erosive esophagitis with continuous areas of inflammation rather than discrete ulcers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Herpes simplex virus causes distinctive punched-out ulcers in the esophagus, particularly noted in immunocompromised patients, diagnosed by endoscopic appearance and confirmed via histopathological findings.</span></span></span></p>",
    "correct_choice_id": 41242,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 54497,
    "choices": [
      {
        "id": 217457,
        "text": "<p><span style=\"font-size:12.0pt;\">KIT</span></p>"
      },
      {
        "id": 217458,
        "text": "<p><span style=\"font-size:12.0pt;\">PDGFR</span></p>"
      },
      {
        "id": 217459,
        "text": "<p><span style=\"font-size:12.0pt;\">SDH</span></p>"
      },
      {
        "id": 217460,
        "text": "<p><span style=\"font-size:12.0pt;\">NRG-1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a marker for gastrointestinal stromal tumor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q5825599",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578779,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) NRG-1</strong></span></p><p><span style=\"font-size:12.0pt;\">Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that commonly present with gastrointestinal bleeding. They are characterized by mutations that lead to the overactivity of tyrosine kinase. The most common mutation associated with GISTs is in the CKIT gene, which leads to the activation of the KIT receptor tyrosine kinase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>NRG-1 (Neuregulin 1):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NRG-1 is a gene that is part of the epidermal growth factor receptor family. It is not associated with GISTs. Instead, NRG-1 is implicated in the pathogenesis of mental health disorders, such as schizophrenia. Therefore, it is not used as a marker for GISTs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. KIT:</strong> KIT mutations are the most common genetic alterations found in GISTs and are critical for the diagnosis and treatment of these tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PDGFR:</strong> Mutations in the PDGFR gene occur in a subset of GISTs and play a role similar to KIT mutations in tumor development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. SDH:</strong> SDH mutations are linked to Carney-Stratakis syndrome and are significant markers in a subset of GISTs. These mutations lead to defects in cellular respiration and are associated with the development of GISTs and paragangliomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NRG-1 is not a marker for gastrointestinal stromal tumors. The primary markers for GISTs include KIT, PDGFR, and SDH mutations.</span></p>",
    "correct_choice_id": 217460,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 54940,
    "choices": [
      {
        "id": 219221,
        "text": "<p><span style=\"font-size:12.0pt;\">Pox virus</span></p>"
      },
      {
        "id": 219222,
        "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
      },
      {
        "id": 219223,
        "text": "<p><span style=\"font-size:12.0pt;\">EBV</span></p>"
      },
      {
        "id": 219224,
        "text": "<p><span style=\"font-size:12.0pt;\">Chickenpox</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient on immunosuppressive therapy presents with cough, fever, and pneumonia. A biopsy reveals the cells shown in the image. Which organism is responsible for this finding? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/5_6228736506677170931.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p>",
    "unique_key": "Q3186967",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578740,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) CMV (Cytomegalovirus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided shows cells with the characteristic \"owl eye\" appearance, which is a classic histopathological finding in infections caused by Cytomegalovirus (CMV). CMV is a type of herpesvirus that can cause severe infections, especially in immunocompromised patients, such as those on immunosuppressive therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"owl eye\" appearance refers to the large intranuclear inclusion bodies surrounded by a clear halo, resembling an owl's eye. This appearance is due to the replication of the virus within the nucleus of the infected cell, leading to the formation of these inclusion bodies. <strong>In CMV infections, both intranuclear and intracytoplasmic basophilic inclusions can be observed, which is a key diagnostic feature.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV commonly causes pneumonia in immunocompromised individuals, such as those with HIV/AIDS, organ transplant recipients, or patients on immunosuppressive therapy. The virus can also cause other severe complications, including retinitis, colitis, and encephalitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note \u2013 <strong>Ganciclovir - </strong>Preferred antiviral medication for treating CMV infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pox virus:</strong> Poxviruses, such as the variola virus (which causes smallpox), typically produce skin lesions and are not known for causing the \"owl eye\" appearance in cells. Therefore, this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. EBV (Epstein-Barr Virus):</strong> EBV is associated with conditions such as infectious mononucleosis and certain lymphomas, like Burkitt's lymphoma. It does not typically produce the \"owl eye\" inclusions seen in CMV infection, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chickenpox (Varicella-Zoster Virus):</strong> Chickenpox, caused by the varicella-zoster virus, is characterized by vesicular skin lesions and does not produce the \"owl eye\" appearance in histological sections. Therefore, this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"owl eye\" appearance of cells in a biopsy is a hallmark of Cytomegalovirus (CMV) infection, particularly in immunocompromised patients. This feature is crucial for diagnosing CMV-related complications, such as CMV pneumonia.</span></p>",
    "correct_choice_id": 219222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ]
  },
  {
    "id": 10279,
    "choices": [
      {
        "id": 41082,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carcinoid tumor</span></span></span></p>"
      },
      {
        "id": 41083,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
      },
      {
        "id": 41084,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gastrointestinal stromal tumor</span></span></span></p>"
      },
      {
        "id": 41085,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gastric adenocarcinoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is an epithelial tumor of the stomach? (NEET PG 2018)</span></span></span></p>",
    "unique_key": "Q9678501",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578747,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Gastric adenocarcinoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gastric adenocarcinoma is an epithelial tumor of the stomach.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma is the most common malignancy (90% cases) of the stomach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/3_0ateZOy.jpg\" style=\"height:191px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carcinoid tumor:</span></strong><span style=\"font-size:12.0pt\"> This is a neuroendocrine tumor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lymphoma:</span></strong><span style=\"font-size:12.0pt\"> Represents a type of blood cancer originating from lymphocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gastrointestinal stromal tumor:</span></strong><span style=\"font-size:12.0pt\"> A non-epithelial tumor that arises from the interstitial cells of Cajal in the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-114417.png\" style=\"height:633px; width:1000px\" /></p>",
    "correct_choice_id": 41085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10066,
    "choices": [
      {
        "id": 40230,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gonadal mosaicism</span></span></span></p>"
      },
      {
        "id": 40231,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genomic imprinting</span></span></span></p>"
      },
      {
        "id": 40232,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anticipation</span></span></span></p>"
      },
      {
        "id": 40233,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete penetrance</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the phenomenon of a differential effect of the same gene from different parents?</span> <span style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q9100550",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578773,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Genomic imprinting</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic Imprinting is the phenomenon of a differential effect of the same gene from different parents.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important functional differences exist between the paternal allele and the maternal allele. These differences result from an epigenetic process, called imprinting. In most cases, imprinting selectively inactivates either the maternal or paternal allele. Thus, maternal imprinting refers to transcriptional silencing of the maternal allele, whereas paternal imprinting implies that the paternal allele is inactivated. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic imprinting is&nbsp;a process of silencing genes through DNA methylation. The repressed allele is methylated, while the active allele is unmethylated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Prader-Willi syndrome and Angelman syndrome. Both of these syndromes can be caused by imprinting or other errors involving genes on the long arm of chromosome 15.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Gonadal mosaicism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Gonadal mosaicism refers to the presence of more than one genetically distinct cell line within the gonads. This can lead to different genetic outcomes in offspring but does not involve the differential effect of the same gene based on parental origin. Therefore, it is not related to genomic imprinting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Anticipation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Anticipation is a phenomenon where a genetic disorder appears earlier and with increased severity in successive generations. This is different from genomic imprinting, as it does not involve the differential effects of a gene based on whether it is inherited from the mother or the father.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Incomplete penetrance</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Incomplete penetrance occurs when not all individuals carrying a disease-causing mutation exhibit the disease phenotype. This concept is unrelated to the differential effect of a gene based on its parental origin and does not describe genomic imprinting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Genomic imprinting is an epigenetic process where the same gene can have different effects depending on whether it is inherited from the mother or the father, typically through mechanisms like DNA methylation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 328</span></strong></span></span></p>",
    "correct_choice_id": 40231,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 43950,
    "choices": [
      {
        "id": 175463,
        "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand disease</span></p>"
      },
      {
        "id": 175464,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemophilia A</span></p>"
      },
      {
        "id": 175465,
        "text": "<p><span style=\"font-size:12.0pt;\">Christmas disease</span></p>"
      },
      {
        "id": 175466,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor 12 Deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old female with bleeding disorder, gives family history of her father and sister suffering from the&nbsp;same bleeding disorders. Which is the most likely disorder? (</span><span style=\"font-size:11.0pt;\">INICET NOV 2023)</span></p>",
    "unique_key": "Q3357726",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578754,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Von Willebrand disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand disease is a common inherited bleeding disorder that affects both males and females, and it is typically inherited in an autosomal dominant pattern. This means that males and females have an equal chance of inheriting the disorder from a parent, which is consistent with the family history provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemophilia A:&nbsp;</strong>This is a X-linked recessive disorder primarily affecting males; females are typically carriers unless under rare circumstances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Christmas Disease (Hemophilia B):&nbsp;</strong>Similar to Hemophilia A, this condition is also X-linked recessive, predominantly affecting males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Factor 12 Deficiency</strong>: This is a much rarer condition and usually does not lead to significant bleeding issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand disease is characterized by its autosomal dominant inheritance pattern and affects both genders, making it the most likely diagnosis for a female patient with a family history of bleeding disorders involving both male and female family members.</span></p>",
    "correct_choice_id": 175463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 57623,
    "choices": [
      {
        "id": 229861,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell cancer lung</span></span></span></p>"
      },
      {
        "id": 229862,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenocarcinoma lung</span></span></span></p>"
      },
      {
        "id": 229863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell carcinoma lung</span></span></span></p>"
      },
      {
        "id": 229864,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Large cell carcinoma lung</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient had a pulmonary mass which shows IHC staining with TTF-1 as shown in the image. What is the likely diagnosis in this patient? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf2.jpg\" style=\"height:273px; width:400px\" /></span></span></p>",
    "unique_key": "Q1034235",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578736,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Adenocarcinoma lung</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroid Transcription Factor-1 (TTF-1) is a nuclear protein that is a specific marker for adenocarcinoma of the lung and small cell carcinoma of the lung. However, it is most commonly associated with adenocarcinoma. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TTF-1 positivity indicates that the tumor cells are likely of lung or thyroid origin, with adenocarcinoma being the most common type of lung cancer associated with this marker. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, other markers like Napsin A and surfactant protein A1 are also specific to adenocarcinoma of the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Squamous cell cancer lung:</span></strong><span style=\"font-size:12.0pt\"> Squamous cell carcinoma typically shows markers like <strong>P63, P40, or keratin.</strong> It does not stain positive for TTF-1, differentiating it from adenocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small cell carcinoma lung:</span></strong><span style=\"font-size:12.0pt\"> While TTF-1 can be positive in small cell carcinoma, other specific markers such as <strong>chromogranin, synaptophysin, and INSM-1</strong> are more indicative. TTF-1&#39;s presence alone, along with the given context, makes adenocarcinoma the more likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Large cell carcinoma lung:</span></strong><span style=\"font-size:12.0pt\"> This is generally a diagnosis of exclusion and does not have specific immunohistochemical markers like TTF-1. Large cell carcinoma is generally a diagnosis of exclusion, as it lacks specific markers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TTF-1 is a key immunohistochemical marker that strongly suggests adenocarcinoma of the lung, particularly when observed in a pulmonary mass.</span></span></span></p>",
    "correct_choice_id": 229862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10364,
    "choices": [
      {
        "id": 41422,
        "text": "<p><span style=\"font-size:12.0pt;\">ANA</span></p>"
      },
      {
        "id": 41423,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti GBM antibodies</span></p>"
      },
      {
        "id": 41424,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV RNA</span></p>"
      },
      {
        "id": 41425,
        "text": "<p><span style=\"font-size:12.0pt;\">Urine immunoelectrophoresis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 51-year-old male patient presents to the clinic with complaints of hematuria. Upon examination, he is found to be normotensive and has pedal edema. Further investigations reveal a lack of glycosuria and a creatinine level of 9. A renal biopsy is performed, and the results are shown below. Which of the following investigations should be conducted to identify the underlying disease? (NEET PG 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uVeTE60.png\" width=\"326\" height=\"213\"></p>",
    "unique_key": "Q4849477",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578791,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Anti GBM antibodies</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapidly progressive glomerulonephritis (RPG) is suspected based on the clinical history and microscopy showing crescents. Among the options presented, anti-GBM antibody testing should be performed because it is part of the RPGN&nbsp;work-up.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HISTOLOGY:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glomeruli \u2014 Regardless of the underlying cause, all forms of RPGN exhibit pathognomonic 'crescents' on the inside of Bowman's capsules. Crescents compress the glomerular tuft and obliterate the Bowman's space.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/crescentic-glomerulonephritis.png\" alt=\"\" width=\"400\" height=\"307\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/11/untitled-17.jpg\" alt=\"\" width=\"1000\" height=\"585\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ANA:&nbsp;</strong>Antinuclear antibody (ANA) testing is used for diagnosing autoimmune diseases such as systemic lupus erythematosus (SLE), which is more typically associated with Type II RPGN. It is not the primary investigation for Type I RPGN.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV RNA:&nbsp;</strong>This test is used for detecting HIV infection. While HIV can cause kidney disease, it is not specifically associated with the pathology seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urine immunoelectrophoresis:&nbsp;</strong>This test is used to detect abnormal proteins in the urine, such as in multiple myeloma. It is not relevant for diagnosing RPGN, specifically Type I RPGN.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Testing for anti-GBM antibodies is crucial in the diagnosis of rapidly progressive glomerulonephritis (RPGN) with crescents on histology, particularly for identifying Type I RPGN (anti-GBM disease).</span></p>",
    "correct_choice_id": 41423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9801,
    "choices": [
      {
        "id": 39171,
        "text": "<p><span style=\"font-size:12.0pt;\">TdT</span></p>"
      },
      {
        "id": 39172,
        "text": "<p><span style=\"font-size:12.0pt;\">CD1a</span></p>"
      },
      {
        "id": 39173,
        "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
      },
      {
        "id": 39174,
        "text": "<p><span style=\"font-size:12.0pt;\">Cytokeratin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not usually involved in the immunohistochemistry of acute lymphoblastic leukemia? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q1379460",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578769,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Cytokeratin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytokeratin is not a marker of acute lymphoblastic leukemia (ALL). It is an epithelial cell marker for thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immunophenotype in ALL \u2013</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Terminal deoxynucleotidyl-transferase (TdT), a specialized DNA polymerase, is positive in more than 95% of cases.</span></li><li><span style=\"font-size:12.0pt;\">Lymphoblasts usually express the pan B-cell marker CD19 and the transcription factor PAX5, as well as CD10.</span></li><li><span style=\"font-size:12.0pt;\">More mature \u201clate pre-B\u201d ALLs express CD10, CD19, CD20, and cytoplasmic IgM heavy chain (\u03bc chain).</span></li><li><span style=\"font-size:12.0pt;\">T-ALLs are arrested at various stages of pre-T cell development. In most cases the cells are positive for CD1, CD2, CD5, and CD7.</span></li><li><span style=\"font-size:12.0pt;\">\u201cLate\u201d pre-T cell tumors are positive CD3, CD4, and CD8</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-184729.png\" alt=\"\" width=\"1000\" height=\"380\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. TdT</strong>: A highly specific marker for ALL, present in over 95% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. CD1a</strong>: Commonly expressed in T-ALL, particularly in early T-cell development stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. CD3</strong>: A marker for T-cell lineage, used in identifying T-ALL and distinguishing it from B-cell lineage ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cytokeratin&nbsp;</strong>is not a marker for <strong>acute lymphoblastic leukemia (ALL)</strong> and is instead an epithelial cell marker used in identifying epithelial tumors such as thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Pg 111</strong></span></p>",
    "correct_choice_id": 39174,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 50489,
    "choices": [
      {
        "id": 201499,
        "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol Cleft</span></p>"
      },
      {
        "id": 201500,
        "text": "<p><span style=\"font-size:12.0pt;\">Foam Cells</span></p>"
      },
      {
        "id": 201501,
        "text": "<p><span style=\"font-size:12.0pt;\">Smooth Muscle Cells</span></p>"
      },
      {
        "id": 201502,
        "text": "<p><span style=\"font-size:12.0pt;\">Glycogen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">On a histopathological slide of an atherosclerotic plaque, what does the presence of needle-shaped empty spaces indicate? (NEET PG 2016)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:1280/702;width:95.78%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_FZssdPM.png\" width=\"1280\" height=\"702\"></span></p>",
    "unique_key": "Q3845885",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578763,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: A. Cholesterol Cleft</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In atherosclerotic plaques, the characteristic needle-shaped empty spaces observed on histopathology represent cholesterol clefts. These spaces form when cholesterol crystals are dissolved during routine tissue processing, leaving behind characteristic empty clefts. They are typically found in the necrotic core of the atherosclerotic plaque, alongside foam cells, necrotic debris, fibrin, and other plasma proteins. These crystalline cholesterol deposits contribute to the \"grumous\" (soft and friable) nature of the lipid core in advanced atheromas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Foam Cells</strong> - These are lipid-laden macrophages and smooth muscle cells found in atherosclerotic plaques, but they appear as cells with foamy cytoplasm due to accumulated lipid droplets, not as empty needle-shaped spaces. Foam cells are a key feature of atherosclerotic lesions, particularly in early fatty streaks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Smooth Muscle Cells</strong> - These cells are present in atherosclerotic plaques, particularly in the fibrous cap, but they appear as spindle-shaped cells with nuclei, not as empty spaces. Smooth muscle cells play an important role in plaque stabilization through ECM production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glycogen</strong> - Glycogen deposits appear as clear spaces within cell cytoplasm but have a different morphology than cholesterol clefts and are not typically a prominent feature of atherosclerotic plaques. Glycogen is more commonly observed in glycogen storage diseases or in certain liver pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cholesterol clefts, appearing as characteristic needle-shaped empty spaces in histopathology, are hallmark features of advanced atherosclerotic plaques, representing crystalline cholesterol deposits that have been dissolved during tissue processing.</span></p>",
    "correct_choice_id": 201499,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10490,
    "choices": [
      {
        "id": 41926,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff body; Rheumatic heart disease</span></span></span></p>"
      },
      {
        "id": 41927,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcification of valve; Mitral stenosis</span></span></span></p>"
      },
      {
        "id": 41928,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Granuloma; Sarcoidosis</span></span></span></p>"
      },
      {
        "id": 41929,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-caseating granuloma; Tuberculosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with complaints of dyspnea on exertion for 1 month. Echocardiography showed the presence of mitral stenosis and left ventricular hypertrophy. Identify the histopathological finding given below and the probable diagnosis? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-392.jpg\" style=\"height:200px; width:300px\" /></span></span></p>",
    "unique_key": "Q7505772",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578790,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Aschoff body; Rheumatic heart disease</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion shown in the histopathological slide is Aschoff&#39;s body and the most probable diagnosis is rheumatic heart disease (RHD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Aschoff&#39;s bodies have the following components:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anitschkow cells or plump macrophages</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abundant cytoplasm</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caterpillar cells - refer to centrally condensed chromatin into slender, wavy ribbons</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foci of fibrinoid necrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff&#39;s giant cells - multinucleated larger macrophages</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">T-cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Plasma cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcification of valve; Mitral stenosis</span></strong><span style=\"font-size:12.0pt\">: While mitral stenosis can result from calcification, it is more typically associated with chronic rheumatic heart disease, which involves Aschoff bodies rather than calcification alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Granuloma; Sarcoidosis</span></strong><span style=\"font-size:12.0pt\">: Sarcoidosis is characterized by non-caseating granulomas, but it does not present with Aschoff bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Non-caseating granuloma</span></strong><span style=\"font-size:12.0pt\">:<strong> Tuberculosis:</strong> Tuberculosis typically presents with caseating granulomas, not Aschoff bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aschoff bodies&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are indicative of <strong>Rheumatic heart disease (RHD)</strong>, and their presence supports the diagnosis in a patient with clinical features such as mitral stenosis and left ventricular hypertrophy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1044</span></strong></span></span></p>",
    "correct_choice_id": 41926,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57622,
    "choices": [
      {
        "id": 229857,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I vWD presents with severe bleeding since birth</span></span></p>"
      },
      {
        "id": 229858,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II vWD has reduced activity of von Willebrand factor</span></span></p>"
      },
      {
        "id": 229859,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III vWD has very low levels of von Willebrand factor</span></span></p>"
      },
      {
        "id": 229860,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type III vWD presents clinically as a severe disease</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is false about von Willebrand disease? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q6004978",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578735,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Type I vWD presents with severe bleeding since birth</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Von Willebrand disease (vWD) is the most common inherited bleeding disorder and is classified into three main types: Type I, Type II, and Type III.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Type I vWD</span></strong><span style=\"font-size:12.0pt\"> is the most common form and is characterized by a mild reduction in the quantity of von Willebrand factor (vWF). It typically presents with mild to moderate mucocutaneous bleeding rather than severe bleeding from birth, making option A false.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Type II vWD</span></strong><span style=\"font-size:12.0pt\"> involves a qualitative defect of vWF, leading to reduced activity rather than quantity, and presents with moderate bleeding tendencies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Type III vWD</span></strong><span style=\"font-size:12.0pt\"> is the most severe form, with very low levels or complete absence of vWF, leading to <strong>severe bleeding</strong> symptoms. This type is rare but clinically severe.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Type II vWD has reduced activity of von Willebrand factor:</span></strong><span style=\"font-size:12.0pt\"> This statement is true as Type II vWD is characterized by a functional defect in the von Willebrand factor, affecting its activity rather than the amount.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Type III vWD has very low levels of von Willebrand factor:</span></strong><span style=\"font-size:12.0pt\"> This is correct; Type III vWD is associated with very low or absent levels of vWF, causing severe bleeding tendencies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Type III vWD presents clinically as a severe disease:</span></strong><span style=\"font-size:12.0pt\"> This is true. Due to extremely low levels of vWF, Type III vWD is associated with severe clinical manifestations, including spontaneous bleeding episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Type I von Willebrand disease presents with mild to moderate bleeding and is the least severe form, contrasting with Type III, which has very low vWF levels and presents as a severe disease.</span></span></span></p>",
    "correct_choice_id": 229857,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10429,
    "choices": [
      {
        "id": 41682,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Leukemia</span></span></span></p>"
      },
      {
        "id": 41683,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lung cancer</span></span></span></p>"
      },
      {
        "id": 41684,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bladder cancer</span></span></span></p>"
      },
      {
        "id": 41685,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin cancer</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with occupational exposure to benzene presents with repeated infections, easy fatigability, weight loss, and evening rise of temperature. This occupational exposure will predispose him to which of the following cancers? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q4915900",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578765,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Leukemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Benzene exposure at work increases the risk of developing leukemia. The clinical history of repeated infections, easy fatigability, weight loss, and evening temperature rise with benzene exposure points to<strong> leukemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatic CYP2E1 converts benzene to an epoxide</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The epoxide and other metabolites disrupt bone marrow progenitor cell differentiation, resulting in marrow aplasia and acute myeloid leukemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin lymphoma have all been linked to benzene exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Lung Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Exposure to <strong>arsenic and its compounds, asbestos, beryllium</strong> and its compounds, chromium compounds, nickel compounds, radon, and its decay products can cause lung cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Bladder Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Exposure to aryl amines, particularly <strong>2-naphthylamine</strong> and related compounds, <strong>cyclophosphamide,</strong> cigarette smoking, irradiation can cause bladder cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Skin Cancer</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Exposure to <strong>UV rays, arsenic</strong>, and its compounds can cause skin cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Occupational exposure to benzene predisposes individuals to leukemia, as benzene metabolites disrupt bone marrow progenitor cell differentiation, leading to marrow aplasia and various types of leukemia. The clinical presentation of repeated infections, easy fatigability, weight loss, and evening rise of temperature in a patient with benzene exposure is highly suggestive of leukemia.</span></span></span></p>",
    "correct_choice_id": 41682,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 31888,
    "choices": [
      {
        "id": 127422,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liver cirrhosis </span></span></span></p>"
      },
      {
        "id": 127423,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis </span></span></span></p>"
      },
      {
        "id": 127424,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatocellular carcinoma </span></span></span></p>"
      },
      {
        "id": 127425,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cholangiocarcinoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A chronic alcoholic presented with abdominal pain, jaundice and weight loss. He has hypoglycemia and elevated alpha fetoprotein levels (250IU) but has normal AST and ALT. Which of the following is a likely diagnosis of the patient? (NEET PG 2023)</span></span></p>",
    "unique_key": "Q7845658",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578734,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hepatocellular carcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A history of chronic alcohol intake with abdominal pain, jaundice and weight loss is suggestive of a liver dysfunction.&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-192839.jpg\" style=\"height:311px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Differential Diagnosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Liver cirrhosis:</span></strong><span style=\"font-size:12.0pt\"> Often has elevated liver enzymes (AST, ALT) and may present with similar symptoms but is not typically associated with high AFP levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hepatitis:</span></strong><span style=\"font-size:12.0pt\"> Would show elevated AST and ALT levels, ruling out this option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cholangiocarcinoma:</span></strong><span style=\"font-size:12.0pt\"> May present with jaundice and weight loss but is not typically associated with elevated AFP levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatocellular carcinoma should be considered in a chronic alcoholic presenting with abdominal pain, jaundice, weight loss, hypoglycemia, and elevated alpha-fetoprotein levels, especially with normal AST and ALT levels.</span></span></span></p>",
    "correct_choice_id": 127424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9774,
    "choices": [
      {
        "id": 39063,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Auer rod</span></span></span></p>"
      },
      {
        "id": 39064,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flaming promyelocyte</span></span></span></p>"
      },
      {
        "id": 39065,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Faggot cell</span></span></span></p>"
      },
      {
        "id": 39066,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dusky promyelocyte</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male patient is diagnosed with acute myeloid leukemia. The peripheral blood smear picture is given in the image. The cell indicated by the arrow is best described as:</span></span> (AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/926.jpg\" style=\"height:211px; width:300px\" /></span></span></p>",
    "unique_key": "Q8789298",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578755,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Faggot cell</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The picture shows multiple <strong>Auer rods c</strong>lustered in a single cell resembling a bundle of sticks.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Such cells are called<strong> faggot cells</strong> (faggot meaning bundle of sticks in French). Faggot cells are characteristic of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML) associated with the t(15;17) translocation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of faggot cells is particularly indicative of APL, where the leukemic promyelocytes have an abundance of Auer rods. Auer rods are distinctive needle-like azurophilic granules formed by the fusion of primary (azurophilic) granules. While Auer rods can be seen in other subtypes of AML, the clustering of these rods within a single cell to form a faggot cell is most commonly associated with APL.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Since the question is particularly about the cell, the best answer from the given options is faggot cell and not Auer rods.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Auer rods</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Auer rods are distinctive needle-like azurophilic granules present in many cases but particularly numerous in <strong>AML with the t(15;17</strong>) aberration (acute promyelocytic leukemia).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Flaming promyelocyte</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Flaming promyelocyte is an abnormal promyelocyte with disintegrating cytoplasm and liberating Auer rods and granules into the surrounding marrow. Found in APL</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Dusky promyelocyte</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Promyelocytes with fine granules appearing dusky or hazy are called dusky promyelocytes.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A faggot cell, characterized by multiple Auer rods clustered together in a single cell, is highly indicative of acute promyelocytic leukemia (APL). While Auer rods are a feature of various forms of AML, the presence of faggot cells is particularly associated with APL.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg 1154</span></strong></span></span></p>",
    "correct_choice_id": 39065,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 54939,
    "choices": [
      {
        "id": 219217,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
      },
      {
        "id": 219218,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
      },
      {
        "id": 219219,
        "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
      },
      {
        "id": 219220,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the pattern of inheritance with the pedigree chart provided in the image? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/screenshot-2024-08-27-175200.jpg\" alt=\"\" width=\"500\" height=\"252\"></span></p>",
    "unique_key": "Q5097747",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578739,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Mitochondrial inheritance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pedigree chart provided in the image demonstrates a pattern of inheritance where an affected female passes the trait or disease to all of her offspring, regardless of their gender. Additionally, the affected males do not pass the trait to any of their offspring. This pattern is characteristic of mitochondrial inheritance, also known as maternal inheritance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitochondrial DNA (mtDNA) is inherited exclusively from the mother because mitochondria in the sperm are typically not involved in fertilization. Therefore, any mutations in mitochondrial DNA will be passed from an affected mother to all of her children. However, because males do not contribute mitochondria to their offspring, they do not pass on mitochondrial diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Autosomal recessive:</strong> Autosomal recessive inheritance typically requires both parents to carry one copy of the mutated gene, and it affects both males and females equally. The pattern in the pedigree, where all children of an affected female are affected, does not fit an autosomal recessive pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Autosomal dominant:</strong> Autosomal dominant inheritance usually involves a 50% chance of passing the mutated gene from an affected parent to each child, regardless of gender. The pedigree showing all offspring of an affected female being affected, while none of the offspring of an affected male are affected, does not fit this pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. X-linked recessive:</strong> X-linked recessive inheritance usually affects males more frequently, as they have only one X chromosome. Affected males would pass the mutated gene to all of their daughters (who would be carriers) but none of their sons. This pattern does not match the pedigree chart provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance is characterized by the transmission of a trait from an affected mother to all of her offspring, while affected males do not pass the trait to their children. This unique pattern is due to the inheritance of mitochondrial DNA, which is maternally inherited.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Example of Maternal/ mitochondrial inheritance diseases: <strong>Leber's Optic Neuropathy</strong>, MELAS Syndrome (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like manifestation).</span></p>",
    "correct_choice_id": 219220,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "FMGE",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 24746,
    "choices": [
      {
        "id": 98945,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal dominant</span></span></span></p>"
      },
      {
        "id": 98946,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal recessive</span></span></span></p>"
      },
      {
        "id": 98947,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudodominant inheritance</span></span></span></p>"
      },
      {
        "id": 98948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete penetrance</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mode of inheritance from the pedigree chart given below:</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256107.jpg\" style=\"height:273px; width:400px\" /></span></span></p>",
    "unique_key": "Q2851521",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578750,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Autosomal dominant </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The pedigree chart given is suggestive of an autosomal dominant Disorders</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256108.jpg\" style=\"height:197px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autosomal dominant inheritance is characterized by a consistent appearance of affected individuals in every generation, with no sex bias and manifestation in individuals who carry one copy of the mutant allele.</span></span></span></p>",
    "correct_choice_id": 98945,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10320,
    "choices": [
      {
        "id": 41246,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Catalase</span></span></span></p>"
      },
      {
        "id": 41247,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Collagenase</span></span></span></p>"
      },
      {
        "id": 41248,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elastase</span></span></span></p>"
      },
      {
        "id": 41249,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phospholipase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha 1-antitrypsin is the major inhibitor of the enzyme: (NEET PG 2019)</span></span></p>",
    "unique_key": "Q4460136",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578771,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Elastase </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha 1-antitrypsin is the major inhibitor of the enzyme neutrophil elastase.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On serum electrophoresis, alpha-1-antitrypsin (-1-AT), also known as alpha&nbsp;1-protease inhibitor, is a glycoprotein that typically makes up the alpha1-globulin fraction of the plasma proteins.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is typically produced in the liver and found in macrophages, circulating blood, and tissue fluids.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The name &quot;Alpha1-protease inhibitor&quot; comes from the fact that alpha1AT&#39;s primary role in the body is to inhibit proteases. The proteases, particularly the elastases, come from neutrophils.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The anti-elastase activity of alpha1-AT prevents neutrophil elastase from digesting lung parenchyma, despite its ability to do so.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the proteinase inhibitor (Pi) locus on <strong>chromosome 14</strong>, co-dominantly expressed genes that code for 1-antitrypsin are located. The Pi locus has a wide variety of alleles and is highly polymorphic.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Those who have the alpha1-AT deficit develop <strong>panacinar</strong> <strong>pulmonary emphysema.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-391.jpg\" style=\"height:261px; width:400px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Catalase:</span></strong><span style=\"font-size:12.0pt\"> Not primarily inhibited by A1AT; it is an antioxidant enzyme.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Collagenase:</span></strong><span style=\"font-size:12.0pt\"> Also not a primary target of A1AT; these enzymes break down collagen in connective tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Phospholipase:</span></strong><span style=\"font-size:12.0pt\"> Not inhibited by A1AT; involved in the hydrolysis of phospholipids.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha 1-antitrypsin&#39;s critical role is to inhibit neutrophil elastase, thus protecting connective tissue from inflammatory damage, particularly in the lungs and liver.</span></span></span></p>",
    "correct_choice_id": 41248,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 24747,
    "choices": [
      {
        "id": 98949,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-a, 2-d, 3-b, 4-c</span></span></span></p>"
      },
      {
        "id": 98950,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-a, 3-b, 4-d</span></span></span></p>"
      },
      {
        "id": 98951,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-b, 2-d, 3-a, 4-c</span></span></span></p>"
      },
      {
        "id": 98952,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-b, 3-a, 4-d</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following disorders with their genetic abnormalities.</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256109.jpg\" style=\"height:134px; width:700px\" /></span></span></p>",
    "unique_key": "Q4179652",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578751,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 1-b, 2-d, 3-a, 4-c </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HUNTINGTON CHOREA</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256112.jpg\" style=\"height:235px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EDWARD&#39;S SYNDROME</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256113.jpg\" style=\"height:240px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256114.jpg\" style=\"height:268px; width:300px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PATAU SYNDROME</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256115.jpg\" style=\"height:252px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256116.jpg\" style=\"height:265px; width:300px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SICKLE CELL ANEMIA</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256117.jpg\" style=\"height:296px; width:600px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256110.jpg\" style=\"height:143px; width:700px\" /></p>",
    "correct_choice_id": 98951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 9964,
    "choices": [
      {
        "id": 39822,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell cycle will stop at G2</span></p>"
      },
      {
        "id": 39823,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell cycle will stop at G1</span></p>"
      },
      {
        "id": 39824,
        "text": "<p><span style=\"font-size:12.0pt;\">There will be no effect on cell cycle as RB gene phosphorylation is not needed</span></p>"
      },
      {
        "id": 39825,
        "text": "<p><span style=\"font-size:12.0pt;\">The cell cycle progresses and cell divides</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">If the RB gene is hypophosphorylated, which of the following will happen? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q2040459",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578783,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cell cycle will stop at G1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the retinoblastoma (RB) gene is hypophosphorylated, then cell cycle will stop at G1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Rb protein is a tumor suppressor, which plays a pivotal role in the negative control of the cell cycle and in tumor progression. It has been shown that Rb protein (pRb) is responsible for a major G1 checkpoint, blocking S-phase entry and cell growth by binding to and inactivating a transcription factor (E2F). The phosphorylation of RB results in the release of E2F activating gene transcription and cell-cycle progression occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/42.jpg\" alt=\"\" width=\"562\" height=\"332\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Cell cycle will stop at G2:</strong> This is incorrect because the Rb protein specifically regulates the G1 to S phase transition, not the G2 phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. There will be no effect on cell cycle as RB gene phosphorylation is not needed:</strong> This is incorrect. The phosphorylation state of the Rb protein is crucial for its function in regulating the cell cycle. Hypophosphorylated Rb actively suppresses cell cycle progression at G1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. The cell cycle progresses and cell divides:</strong> This is incorrect because the hypophosphorylated form of Rb prevents the cell from progressing past the G1 phase, thereby halting cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hypophosphorylated state of the Rb protein prevents the cell cycle from progressing past the G1 phase by binding to and inactivating E2F, thereby acting as a crucial checkpoint in preventing uncontrolled cell proliferation.</span></p>",
    "correct_choice_id": 39823,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 9927,
    "choices": [
      {
        "id": 39674,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 5</span></p>"
      },
      {
        "id": 39675,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 39676,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 5</span></p>"
      },
      {
        "id": 39677,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which mediators involved in the early phase of type 1 hypersensitivity?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Mast cell</span></li><li><span style=\"font-size:12.0pt;\">Histamine</span></li><li><span style=\"font-size:12.0pt;\">Neutrophils</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandins</span></li><li><span style=\"font-size:12.0pt;\">Leukotrienes</span></li></ol>",
    "unique_key": "Q7229439",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578766,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 4, 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type 1 hypersensitivity</strong> reactions, also known as immediate hypersensitivity reactions, are typically triggered by allergens and involve the rapid release of mediators from mast cells. The <strong>early phase</strong> of type 1 hypersensitivity involves several key mediators:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mast cells (1)</strong>: Play a central role in initiating the reaction. When IgE antibodies on the surface of mast cells bind to an allergen, the mast cells degranulate, releasing various mediators.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histamine (2)</strong>: One of the primary mediators released from mast cells, responsible for many of the acute symptoms of allergic reactions, such as vasodilation, increased vascular permeability, and smooth muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prostaglandins (4)</strong>: Specifically, <strong>Prostaglandin D2 (PGD2)</strong>, is produced by mast cells and contributes to vasodilation, bronchoconstriction, and increased mucus secretion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Leukotrienes (5)</strong>: Specifically, <strong>Leukotrienes C4 and D4</strong> are potent mediators that cause prolonged bronchoconstriction, increased vascular permeability, and mucus production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Neutrophils (3)</strong>, while involved in various immune responses, are not typically considered mediators of the early phase of type 1 hypersensitivity. They are more associated with later phases of inflammation or other types of immune responses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Early phase&nbsp;</strong>of type 1 hypersensitivity involves Mast cells, Histamine, Prostaglandins (D2) and Leukotrienes (C4 and D4).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-174004.jpg\" alt=\"\" width=\"1000\" height=\"287\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 377</strong></span></p>",
    "correct_choice_id": 39676,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 65186,
    "choices": [
      {
        "id": 259921,
        "text": "<p><span style=\"font-size:12.0pt;\">Necrosis</span></p>"
      },
      {
        "id": 259922,
        "text": "<p><span style=\"font-size:12.0pt;\">Apoptosis</span></p>"
      },
      {
        "id": 259923,
        "text": "<p><span style=\"font-size:12.0pt;\">Emperipolesis</span></p>"
      },
      {
        "id": 259924,
        "text": "<p><span style=\"font-size:12.0pt;\">Entosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In which of the following processes does one cell engulf another cell without degrading it? (Twisted PYQ)</span></p>",
    "unique_key": "Q1860498",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578743,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Emperipolesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Emperipolesis is the process in which one cell actively enters another cell but remains intact without being degraded. Unlike entosis, in which the engulfed cell is digested by the host cell, emperipolesis allows the engulfed cell to persist and sometimes exit the host cell later. This phenomenon is seen in physiological and pathological processes, such as in immune surveillance or during interactions between cancer and immune cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/2.png\" width=\"1037\" height=\"946\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Necrosis</strong>: Incorrect. Necrosis is an uncontrolled form of cell death due to injury or damage, leading to cell lysis and inflammation. It does not involve a cell-in-cell appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apoptosis</strong>: Incorrect. Apoptosis is a programmed form of cell death characterized by apoptotic bodies and phagocytosis of the remnants, but it does not involve a cell-in-cell structure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Entosis</strong>: Incorrect. Entosis is a process where one cell actively engulfs another cell, leading to its degradation within lysosomes, creating a characteristic \"cell-in-cell\" appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Emperipolesis is distinct from other processes like entosis, as it involves the engulfment of one cell into another without degradation. Understanding this phenomenon is crucial in identifying its roles in immune regulation and pathological conditions like cancer.</span></p>",
    "correct_choice_id": 259923,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 65185,
    "choices": [
      {
        "id": 259917,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo E1</span></p>"
      },
      {
        "id": 259918,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo E2</span></p>"
      },
      {
        "id": 259919,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo E3</span></p>"
      },
      {
        "id": 259920,
        "text": "<p><span style=\"font-size:12.0pt;\">Apo E4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is protective against Alzheimer\u2019s disease? (Twisted PYQ)</span></p>",
    "unique_key": "Q9896336",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578742,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Apo E2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Apolipoprotein E2 (Apo E2) is associated with a decreased risk of developing Alzheimer\u2019s disease. It is believed to have a protective effect due to its role in promoting the efficient clearance of amyloid-beta from the brain, which is a key pathological feature of Alzheimer's disease. Among the ApoE alleles, ApoE2 has the lowest affinity for amyloid-beta and is less likely to contribute to plaque formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Apo E1</strong>: Incorrect. Apo E1 is not commonly associated with Alzheimer\u2019s disease or its risk profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Apo E3</strong>: Incorrect. Apo E3 is the most prevalent allele in the population and is considered neutral in terms of Alzheimer\u2019s disease risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Apo E4</strong>: Incorrect. Apo E4 is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease, increasing both the risk and the severity of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While Apo E4 increases the risk of Alzheimer\u2019s disease, Apo E2 is protective due to its role in reducing amyloid-beta accumulation in the brain. Understanding the roles of ApoE alleles in Alzheimer\u2019s disease can inform genetic counseling and research on therapeutic interventions.</span></p>",
    "correct_choice_id": 259918,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 9813,
    "choices": [
      {
        "id": 39219,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hemangioblastoma</span></span></span></p>"
      },
      {
        "id": 39220,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 39221,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      },
      {
        "id": 39222,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are small round blue cell tumors except: (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q2026209",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578775,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hemangioblastoma</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is not a small round blue cell tumor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Many childhood tumors have been collectively referred to as small round blue cell tumors due to their primitive histologic appearance. </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The differential diagnosis of such tumors includes neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, Ewing sarcoma/primitive neuroectodermal tumor, medulloblastoma and retinoblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Ewing&#39;s sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing&#39;s sarcoma is a classic example of a small round blue cell tumor. It is a highly malignant tumor that primarily affects bone and soft tissues, particularly in children and young adults.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a small round blue cell tumor of the eye, commonly seen in children. It is characterized by the presence of small, undifferentiated cells with hyperchromatic nuclei.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Neuroblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Neuroblastoma is another example of a small round blue cell tumor. It arises from neural crest cells and is most commonly found in the adrenal glands or along the sympathetic chain.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is <strong>not</strong> classified as a small round blue cell tumor, unlike Ewing&#39;s sarcoma, retinoblastoma, and neuroblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and cotrans pathologic basis of disease 8<sup>th</sup> edition pg 882</span></strong></span></span></p>",
    "correct_choice_id": 39219,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 14631,
    "choices": [
      {
        "id": 58485,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hereditary spherocytosis</span></span></span></p>"
      },
      {
        "id": 58486,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G6PD deficiency </span></span></span></p>"
      },
      {
        "id": 58487,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immune thrombocytopenia</span></span></span></p>"
      },
      {
        "id": 58488,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common indication for elective splenectomy is? (</span></span>FMGE Jan 2023)</p>",
    "unique_key": "Q9380831",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578748,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Immune thrombocytopenia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most common indication for elective splenectomy is Immune thrombocytopenia. Splenectomy is performed when patients do not respond to medical therapy. ITP is an autoimmune disorder characterized by a low platelet count and increased risk of bleeding. The spleen is responsible for the destruction of platelets, and its removal helps to increase platelet count and reduce the risk of bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indications for elective splenectomy include:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hereditary Spherocytosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immune Thrombocytopenic Purpura (ITP)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thalassemia: </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersplenism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Splenic Tumors or Cysts</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Splenic Abscess or Infarction</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hereditary spherocytosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While splenectomy is indicated in this condition, it is not the most common indication compared to ITP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. G6PD deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Splenectomy is not a typical treatment for G6PD deficiency, which is managed by avoiding oxidative stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sickle cell anemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Splenectomy may be performed in some cases of sickle cell disease, but it is not the most common indication compared to ITP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common indication for elective splenectomy is Immune Thrombocytopenic Purpura (ITP).</span></span></span></p>",
    "correct_choice_id": 58487,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 9846,
    "choices": [
      {
        "id": 39350,
        "text": "<p><span style=\"font-size:12.0pt;\">Spectrin defect is commonly observed</span></p>"
      },
      {
        "id": 39351,
        "text": "<p><span style=\"font-size:12.0pt;\">Spherical cells may be seen</span></p>"
      },
      {
        "id": 39352,
        "text": "<p><span style=\"font-size:12.0pt;\">Cells don't lyse in hypotonic solution</span></p>"
      },
      {
        "id": 39353,
        "text": "<p><span style=\"font-size:12.0pt;\">Cells lyse in hypertonic solution</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding glucose-6-phosphate dehydrogenase deficiency?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2020)</span></p>",
    "unique_key": "Q7436492",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578786,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Spherical cells may be seen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD deficiency can have spherical red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucose-6-phosphate dehydrogenase (G6PD. is an enzyme that helps in the synthesis of NADPH. NADPH helps in keeping glutathione in a reduced state (GSH). This reduced glutathione acts as a defense against oxidative damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In G6PD deficiency, RBCs are exposed to oxidants. These cross-linking of the reactive sulfhydryl groups in the globin chain of hemoglobin. These are then deposited as inclusions in RBC membranes as Heinz bodies. <strong>When these RBCs pass-through spleen, macrophages pluck out these membrane inclusions. The remaining cells are seen as bite cells. Less severely damaged cells lose a part of their membrane, forming spherocytes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/978.jpg\" alt=\"\" width=\"488\" height=\"342\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Spectrin</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Spectrin is a part of the RBC membrane skeleton. It is commonly defective in hereditary spherocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Cells don't lyse in hypotonic solution</strong>: Normal biconcave RBCs have a bit of an 'extra space'. They can accommodate a little fluid when exposed to a hypotonic solution. But spherocytes have already lost a part of its membrane, so are relatively full. Hence if they are placed in a hypotonic solution, they absorb more fluid and result in lysis of RBCs. This forms the basis of testing spherocytes in Hereditary spherocytosis or G6PD and is known as <strong>osmotic fragility testing.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cells lyse in hypertonic solution</strong>: Placing RBCs in a hypertonic solution causes them to lose water and shrink, but significant hemolysis does not typically occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What is G6PD Deficiency?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A genetic enzymopathy, inherited in an X-linked recessive manner.</span></li><li><span style=\"font-size:12.0pt;\">G6PD is an enzyme in the pentose phosphate pathway that generates NADPH, which helps maintain reduced glutathione (GSH).</span></li><li><span style=\"font-size:12.0pt;\">GSH protects red blood cells (RBCs) from oxidative damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What Happens in G6PD Deficiency?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Without enough G6PD, RBCs are vulnerable to oxidative stress, such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Infections</span></li><li><span style=\"font-size:12.0pt;\">Drugs (e.g., sulfa drugs, antimalarials)</span></li><li><span style=\"font-size:12.0pt;\">Fava beans</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key peripheral smear findings:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Bite cells</span></li><li><span style=\"font-size:12.0pt;\">Heinz bodies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In glucose-6-phosphate dehydrogenase (G6PD) deficiency, red blood cells become spherical (spherocytes) due to oxidative damage and the removal of damaged membrane by the spleen, leading to hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp;Robbins and Cotrans pathologic basis of disease 8<sup>th</sup> edition pg 1198-1199</strong></span></p>",
    "correct_choice_id": 39351,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 9845,
    "choices": [
      {
        "id": 39346,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine specimen is used</span></span></span></p>"
      },
      {
        "id": 39347,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Sanger sequencing is used</span></span></span></p>"
      },
      {
        "id": 39348,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Study of fluid in tumor microenvironment</span></span></span></p>"
      },
      {
        "id": 39349,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">DNA is collected in micro vessels</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true regarding liquid-based cytology? (AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q2210963",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578785,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Urine specimen is used </strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology can also be done using a urine specimen. It is commonly used in cervical cancer screening in place of a pap smear.</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology is a method of preparing samples for examination in cytopathology. The sample is collected, normally by a small brush, in the same way as for a conventional smear test, but rather than the smear being transferred directly to a microscope slide, the sample is deposited into a small bottle of preservative liquid. At the laboratory, the liquid is treated to remove other elements such as mucus before a layer of cells is placed on a slide.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology uses:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Used in place of PAP smear for cervical screening (most common use)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Thyroid cyst fluid examination.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Oral lesions</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Body fluids sampling (e.g., urine, pleural effusions), brushing samples (e.g. gastrointestinal tract, lung), and fine needle aspiration.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Sanger sequencing is used</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Sanger sequencing is a method of DNA sequencing and is not related to liquid-based cytology.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Study of fluid in tumor microenvironment</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Liquid-based cytology is not specifically focused on the study of tumor microenvironment fluids; rather, it is a method for preparing and analyzing cellular samples.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DNA is collected in micro vessels</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is not a description of liquid-based cytology but may relate to other molecular biology techniques.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liquid-based cytology can use urine specimens, among others, to prepare samples for cytological examination, offering advantages over traditional smear techniques in terms of sample preservation and clarity.</span></span></span></p>",
    "correct_choice_id": 39346,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "InvestigationBased"
    ]
  },
  {
    "id": 10457,
    "choices": [
      {
        "id": 41794,
        "text": "<p><span style=\"font-size:12.0pt;\">Splenomegaly</span></p>"
      },
      {
        "id": 41795,
        "text": "<p><span style=\"font-size:12.0pt;\">Frontal bossing</span></p>"
      },
      {
        "id": 41796,
        "text": "<p><span style=\"font-size:12.0pt;\">Mechanical second heart sound</span></p>"
      },
      {
        "id": 41797,
        "text": "<p><span style=\"font-size:12.0pt;\">Goitre</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly patient presents with anemia and hemoglobinuria. Investigations reveal increased lactate dehydrogenase (LDH). The peripheral smear image is given below. Which of the following physical examination findings can support the likely diagnosis? (NEET PG 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1_4IRVWmk.jpg\" alt=\"\" width=\"400\" height=\"300\"></span></p>",
    "unique_key": "Q9955292",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578777,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Mechanical second heart sound</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above scenario, which includes anemia, increased LDH, and hemoglobinuria, as well as schistocytes on a peripheral smear, is suggestive of angiopathic hemolytic anemia (MAHA) caused by red cell trauma. A mechanical second heart sound can help to confirm the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Macroangiopathic hemolytic anemia is a type of hemolytic anemia caused by red cell trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Shear forces cause hemolysis in artificial mechanical cardiac valves due to turbulent blood flow and pressure gradients. This traumatic damage causes intravascular hemolysis and the appearance in blood smears of red cell fragments (schistocytes), burr cells, helmet cells, and triangle cells. The same pressure gradients are also responsible for a mechanical heart sound on auscultation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Splenomegaly</strong>: Splenomegaly is often seen in various hemolytic anemias but is not specific for MAHA associated with mechanical heart valves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Frontal bossing</strong>: Frontal bossing is seen in congenital hemolytic anemias such as thalassemia and sickle cell anemia due to extramedullary hematopoiesis, but not typically in MAHA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Goitre</strong>: Goitre is related to thyroid disorders and is not associated with hemolytic anemia or mechanical heart valves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with anemia, hemoglobinuria, increased LDH, and schistocytes on a peripheral smear, the presence of a mechanical second heart sound can support the diagnosis of angiopathic hemolytic anemia due to mechanical heart valves. The mechanical destruction of red blood cells leads to intravascular hemolysis, characteristic laboratory findings, and specific physical examination findings related to the heart valve.</span></p>",
    "correct_choice_id": 41796,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54499,
    "choices": [
      {
        "id": 217465,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intact cell organelle</span></span></span></p>"
      },
      {
        "id": 217466,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Altered cell shape</span></span></span></p>"
      },
      {
        "id": 217467,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enzyme mediated degradation</span></span></span></p>"
      },
      {
        "id": 217468,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internal organelle disintegration with lipid change</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not helpful for differentiating between necrosis and apoptosis?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q7848453",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578780,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) Altered cell shape</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Necrosis and apoptosis are two distinct types of cell death, each with its own characteristics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Altered cell shape</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While cell shape can change in both necrosis and apoptosis, it is not a reliable indicator to differentiate between the two. The more useful parameter is cell size: in necrosis, cells swell, whereas in apoptosis, cells shrink. Therefore, altered cell shape is not particularly helpful in distinguishing necrosis from apoptosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Intact cell organelle</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: During apoptosis, cell organelles remain intact until the late stages when apoptotic bodies form. These bodies contain tightly packed cytoplasmic components and organelles. In contrast, necrosis is characterized by the breakdown and disintegration of organelles. Thus, the presence of intact organelles helps differentiate apoptosis from necrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Enzyme mediated degradation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a hallmark of necrosis. In necrosis, enzymes digest cellular components, leading to the breakdown of organelles and other structures. This feature is not seen in apoptosis, where cellular components are typically preserved until the cell is packaged into apoptotic bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Internal organelle disintegration with lipid change</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Necrosis involves the disintegration of organelles and changes in lipids, leading to the loss of cell membrane integrity. This is not a feature of apoptosis, where the membrane remains intact until late stages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The key features to differentiate necrosis from apoptosis include the state of cell organelles (intact in apoptosis, disintegrated in necrosis), enzyme-mediated degradation (present in necrosis), and internal organelle disintegration with lipid changes (present in necrosis). Altered cell shape alone is not a useful parameter for differentiation.</span></span></span></p>",
    "correct_choice_id": 217466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 32302,
    "choices": [
      {
        "id": 129066,
        "text": "<p><span style=\"font-size:12.0pt;\">Folate deficiency</span></p>"
      },
      {
        "id": 129067,
        "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disease</span></p>"
      },
      {
        "id": 129068,
        "text": "<p><span style=\"font-size:12.0pt;\">Anemia due to renal failure</span></p>"
      },
      {
        "id": 129069,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An adult presented with pallor, fatigue and reduced work capacity. &nbsp;His investigations revealed low RBC count, low hemoglobin, MCV 70fL and MCH24pg. which of the following is the following is the likely diagnosis in this patient? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q7152667",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578756,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Iron deficiency anemia is characterized by low RBC count, low hemoglobin, and microcytic hypochromic indices (MCV &lt; 80 fl and MCH &lt; 27 pg). The patient\u2019s symptoms of pallor, fatigue, and reduced work capacity are typical of anemia. The lab findings of MCV 70 fl (microcytic) and MCH 24 pg (hypochromic) are consistent with iron deficiency anemia, the most common type of anemia worldwide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Folate deficiency</strong>: Causes macrocytic anemia (MCV &gt; 100 fl), which is not consistent with the patient's lab results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anemia of chronic disease</strong>: Typically presents with normocytic or slightly microcytic anemia. However, iron deficiency anemia is more common and fits better with the lab findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anemia due to renal failure</strong>: Usually presents with normocytic anemia, where the MCV is within the normal range (80-100 fl), not microcytic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-161745.jpg\" alt=\"\" width=\"1000\" height=\"152\"></span></p>",
    "correct_choice_id": 129069,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 47539,
    "choices": [
      {
        "id": 189767,
        "text": "<p><span style=\"font-size:12.0pt;\">S</span></p>"
      },
      {
        "id": 189768,
        "text": "<p><span style=\"font-size:12.0pt;\">G2M</span></p>"
      },
      {
        "id": 189769,
        "text": "<p><span style=\"font-size:12.0pt;\">M</span></p>"
      },
      {
        "id": 189770,
        "text": "<p><span style=\"font-size:12.0pt;\">G1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the most radiosensitive phase of a cell cycle?&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q7608474",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578759,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) G2M</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cell cycle consists of several phases, including the quiescent phase (G0), G1 phase, S phase, G2 phase, and M phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The G2/M phase of the cell cycle is the most radiosensitive. This phase is critical for cell division, involving DNA repair mechanisms and the process of mitosis. Radiosensitivity is heightened due to the cells\u2019 high mitotic activity and the presence of condensed chromosomes, which are more susceptible to damage by radiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. S phase:</strong> Cells are synthesizing DNA and are somewhat resistant to radiation because DNA repair enzymes are active. S phase is the most radioresistant phase of the cell cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. M phase:</strong> Although mitosis is a rapid process, its radiosensitivity is slightly less than G2/M phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. G1 phase:</strong> This phase involves the growth and preparation of the cell for DNA synthesis; cells in G1 are less sensitive to radiation compared to G2/M.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note \u2013 Phases of cell cycle \u2013</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/21/screenshot-2024-06-21-113700_bZscd6n.png\" alt=\"\" width=\"500\" height=\"352\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/21/screenshot-2024-06-21-113747_Kkl1BM5.png\" alt=\"\" width=\"1000\" height=\"227\"></p>",
    "correct_choice_id": 189768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10276,
    "choices": [
      {
        "id": 41070,
        "text": "<p><span style=\"font-size:12.0pt;\">Emphysema</span></p>"
      },
      {
        "id": 41071,
        "text": "<p><span style=\"font-size:12.0pt;\">Miliary tuberculosis</span></p>"
      },
      {
        "id": 41072,
        "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
      },
      {
        "id": 41073,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition represented in the image below: (NEET PG 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/2_lKCb6Q7.jpg\" alt=\"\" width=\"250\" height=\"288\"></span></p>",
    "unique_key": "Q7208766",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578744,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Miliary tuberculosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above image represents \u201cmiliary tuberculosis\u201d. Individual lesions are small (2-mm) foci of yellow-white consolidation scattered through the lung parenchyma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Miliary tuberculosis is lymphohematogenous spread of tuberculous infection from primary focus or later stages of tuberculosis. The spread may occur to systemic organs or isolated organ. The spread is either by entry of infection into pulmonary vein producing disseminated or isolated organ lesion in different extra-pulmonary sites (e.g. liver, spleen, kidney, brain and bone marrow) or into pulmonary artery restricting the development of miliary lesions within the lung. The miliary lesions are millet seed-sized (1 mm diameter), yellowish, firm areas without grossly visible caseation necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Emphysema:</strong> This condition is characterized by the abnormal, permanent enlargement of airspaces distal to the terminal bronchioles and the destruction of the alveolar walls. Large subpleural bullae (air-filled spaces &gt;1 cm) may be present, especially in paraseptal emphysema.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HP1YhXX.png\" width=\"271\" height=\"386\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sarcoidosis:</strong> Typically presents with non-caseating granulomas.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LyOe6z1.png\" width=\"272\" height=\"407\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Asbestosis:</strong> Associated with fibrous thickening and plaque formation primarily in the lung bases.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RMhHM1d.png\" width=\"407\" height=\"259\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Miliary tuberculosis appears as small, millet seed-sized yellowish foci scattered throughout the lung parenchyma, indicative of widespread hematogenous dissemination of tuberculosis.</span></p>",
    "correct_choice_id": 41071,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9929,
    "choices": [
      {
        "id": 39682,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor XII</span></span></span></p>"
      },
      {
        "id": 39683,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor VII</span></span></span></p>"
      },
      {
        "id": 39684,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor VIII</span></span></span></p>"
      },
      {
        "id": 39685,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">VWF</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the factor &#39;L&#39; which combines with tissue factor to activate factor IX in given coagulation cascade? (AIIMS MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture20.jpg\" style=\"height:177px; width:300px\" /></p>",
    "unique_key": "Q9813896",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578767,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Factor VII</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The factor marked as &#39;L&#39; is factor VII, which combines with tissue factor to activate factor IX.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture21.jpg\" style=\"height:303px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombin also activates factor XIlI, which is the fibrin stabilizing factor to factor XIlla. This factor XIlla forms covalent cross-links and thereby stabilizes the fibrin clot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Factor XII</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the initiation of the intrinsic pathway, but it does not combine with tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Factor VIII</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Works as a cofactor for Factor IXa in the intrinsic pathway, but it does not combine with tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. VWF (Von Willebrand Factor)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in platelet adhesion and stabilization of Factor VIII but is not involved in the activation of the coagulation cascade by tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor VII is the key clotting factor that combines with tissue factor to activate Factor IX and Factor X, playing a crucial role in the extrinsic pathway of the coagulation cascade.</span></span></span></p>",
    "correct_choice_id": 39683,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 31887,
    "choices": [
      {
        "id": 127418,
        "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase</span></p>"
      },
      {
        "id": 127419,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase &nbsp;&nbsp;</span></p>"
      },
      {
        "id": 127420,
        "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1,4 glucosidase</span></p>"
      },
      {
        "id": 127421,
        "text": "<p><span style=\"font-size:12.0pt;\">Galactosidase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An individual undergoes a bone marrow examination which shows the presence of the cells as shown in the image. Which of the following is the likely enzyme defect associated with this condition? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-192533.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
    "unique_key": "Q3553009",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578733,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glucocerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of gaucher cells with a crumpled paper appearance is suggestive of Gaucher\u2019s disease. It is caused by deficiency of glucocerebrosidase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gaucher's Disease:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pathology:</strong> Gaucher's disease is a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. This enzyme is responsible for breaking down glucocerebroside into glucose and ceramide.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Patients may present with hepatosplenomegaly, anemia, thrombocytopenia, and bone pain or fractures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histopathology:</strong> Gaucher cells are macrophages filled with lipid-laden lysosomes. These cells have a characteristic crumpled paper appearance due to the accumulation of glucocerebroside.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hexosaminidase:&nbsp;</strong>Deficiency causes Tay-Sachs disease, characterized by a cherry-red spot on the macula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Alpha 1,4 glucosidase:&nbsp;</strong>Deficiency causes Pompe disease, characterized by glycogen accumulation in lysosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Galactosidase:&nbsp;</strong>Deficiency causes Fabry disease, characterized by angiokeratomas, acroparesthesia, and renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gaucher cells with a crumpled paper appearance in a bone marrow examination are indicative of Gaucher's disease, caused by a deficiency of the enzyme glucocerebrosidase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gaucher Disease Overview:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_diXjANc.png\" width=\"1061\" height=\"380\"></span></p>",
    "correct_choice_id": 127419,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10281,
    "choices": [
      {
        "id": 41090,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">12 hours</span></span></span></p>"
      },
      {
        "id": 41091,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">24 hours</span></span></span></p>"
      },
      {
        "id": 41092,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6 hours</span></span></span></p>"
      },
      {
        "id": 41093,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">48 hours</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the maximum duration for TRALI to occur after blood transfusion? (NEET PG 2018)</span></span></p>",
    "unique_key": "Q6539922",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578749,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 6 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The maximum duration for TRALI (transfusion-related acute lung injury) to occur after blood transfusion is 6 hours.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TRALI is characterized as sudden onset respiratory failure that occurs during or shortly after a blood transfusion. The pathogenesis is based on a two-hit hypothesis:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Priming event - increased sequestration and sensitization of neutrophils in the lung microvasculature </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Second knock - the factor (most commonly MHC class I antigens) present in the transfused blood product stimulates the primed neutrophils</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pathogenesis of transfusion-related acute lung injury (TRALI):</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dysregulation of Inflammatory Process</span></strong><span style=\"font-size:12.0pt\">: This indicates an imbalance or dysregulation in the normal inflammatory response.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Leukocyte Antigen (Ag) Recipient</span></strong><span style=\"font-size:12.0pt\">: Refers to the recipient&#39;s leukocytes, which play a role in the immune response.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Blood AB Donor</span></strong><span style=\"font-size:12.0pt\">: Indicates the presence of antibodies (AB) in the donated blood.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">First Hit</span></strong><span style=\"font-size:12.0pt\">: Represents an initial insult or trigger such as trauma, sepsis, or neutrophil activation that can activate the immune system.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Endothelial Permeability</span></strong><span style=\"font-size:12.0pt\">: Describes the increased permeability of endothelial cells lining blood vessels.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Second Hit</span></strong><span style=\"font-size:12.0pt\">: Refers to a secondary insult, which in this case is the transfusion of blood components.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transfusion Blood Components</span></strong><span style=\"font-size:12.0pt\">: Represents the infusion of blood products, including lysophosphatidylcholine (Lyso PC).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Endothelial Activation</span></strong><span style=\"font-size:12.0pt\">: Activation of endothelial cells leading to cytokine release, which is the release of signalling molecules involved in immune responses.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Common Pathway</span></strong><span style=\"font-size:12.0pt\">: Illustrates that both the first hit and the second hit converge to activate a common pathway.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Alveolar Capillary Pulmonary Damage</span></strong><span style=\"font-size:12.0pt\">: Indicates the injury and damage occurring in the alveolar-capillary membrane in the lungs.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Respiratory Failure</span></strong><span style=\"font-size:12.0pt\">: Refers to the development of sudden respiratory distress and failure.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">TRALI vs TACO: -</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/14/untitled-367_i7Le7u2.jpg\" style=\"height:456px; width:1000px\" /></p>",
    "correct_choice_id": 41092,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9775,
    "choices": [
      {
        "id": 39067,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
      },
      {
        "id": 39068,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      },
      {
        "id": 39069,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic cirrhosis</span></span></span></p>"
      },
      {
        "id": 39070,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nephrotic syndrome</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the most likely diagnosis based on the given serum electrophoresis image (pink)?</span> </span></span>(AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/927.jpg\" style=\"height:309px; width:400px\" /></span></span></span></p>",
    "unique_key": "Q5263339",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578757,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Nephrotic syndrome</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given electrophoresis picture shows hypoalbuminemia and increased alpha-2 globulin, which is suggestive of nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/928.jpg\" style=\"height:287px; width:677px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/929.jpg\" style=\"height:564px; width:724px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Multiple myeloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Multiple myeloma would typically present with a sharp, monoclonal spike in the gamma region (known as an M-spike or paraprotein spike) due to the overproduction of a single type of immunoglobulin by malignant plasma cells. This pattern is not seen in the provided electrophoresis image.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Tuberculosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Tuberculosis is generally associated with a chronic inflammatory response and can show a polyclonal increase in the gamma region due to chronic immune activation. However, it does not show the specific hypoalbuminemia and alpha-2 globulin increase seen in nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hepatic cirrhosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In hepatic cirrhosis, the electrophoresis pattern often shows a polyclonal increase in the gamma region (polyclonal gammopathy), sometimes with a beta-gamma bridging pattern. This pattern is not consistent with the hypoalbuminemia and alpha-2 globulin increase observed in nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The electrophoresis pattern showing hypoalbuminemia combined with an increase in alpha-2 globulin is most indicative of nephrotic syndrome, reflecting the characteristic loss of albumin and retention of larger plasma proteins in this condition.</span></span></span></p>",
    "correct_choice_id": 39070,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 46800,
    "choices": [
      {
        "id": 186815,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 186816,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemodialysis</span></p>"
      },
      {
        "id": 186817,
        "text": "<p><span style=\"font-size:12.0pt;\">Familial Mediterranean fever</span></p>"
      },
      {
        "id": 186818,
        "text": "<p><span style=\"font-size:12.0pt;\">Senile systemic amyloidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis associated with transthyretin deposition is: (NEET 2016)</span></p>",
    "unique_key": "Q1229319",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578772,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Senile systemic amyloidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Senile systemic amyloidosis is characterized by the deposition of Transthyretin (TTR) in its wild-type form in the heart and other organs of the elderly. This form of amyloidosis is distinct from other types as it involves a normal serum protein (TTR) that binds and transports thyroxine and retinol, rather than a mutated protein or a protein associated with inflammation or dialysis-related conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>A. Multiple myeloma</strong>: Associated with AL amyloidosis, not transthyretin deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>B. Hemodialysis</strong>: Associated with \u03b22-microglobulin amyloidosis (A\u03b22m), not TTR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>C. Familial Mediterranean fever</strong>: Typically leads to AA amyloidosis due to inflammation, not TTR-related amyloidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Senile systemic amyloidosis involves the deposition of normal Transthyretin (TTR) protein, primarily affecting the heart and occurring predominantly in the elderly</span></p>",
    "correct_choice_id": 186818,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 9836,
    "choices": [
      {
        "id": 39311,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 39312,
        "text": "<p><span style=\"font-size:12.0pt;\">Merkel Cell Carcinoma</span></p>"
      },
      {
        "id": 39313,
        "text": "<p><span style=\"font-size:12.0pt;\">Basal Cell Carcinoma</span></p>"
      },
      {
        "id": 39314,
        "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Cancer that least commonly spreads by lymphatic route is: </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q8820329",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578784,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Basal Cell Carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basal cell carcinoma is a locally aggressive tumor that rarely spreads by the lymphatic route.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mutations in sonic hedgehog pathway</strong> are associated with it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Grossly, the most common pattern is a <strong>nodulo-ulcerative basal cell carcinoma</strong> in which a slow-growing small nodule undergoes <strong>central ulceration with pearly, rolled margins</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/963.jpg\" alt=\"\" width=\"400\" height=\"264\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The occasional presence of melanin in this variant of nodular BCC (pigmented BCC. may lead to confusion with melanoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It occurs exclusively on hairy skin, the most common location (90%) being the face, usually above a line from the lobe of the ear to the corner of the mouth. <strong>The most common site is the inner canthus of the eye.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/964.jpg\" alt=\"\" width=\"400\" height=\"400\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Basal cell carcinoma does not show lymphatic or hematogenous metastasis. It is primarily locally invasive</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma often spreads via the lymphatic system, particularly when occurring in the skin or mucous membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Merkel Cell Carcinoma</strong>: This is a rare and aggressive form of skin cancer that frequently metastasizes via the lymphatic system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malignant melanoma</strong>: Melanoma is known for its high metastatic potential, often spreading through both lymphatic and hematogenous routes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Basal cell carcinoma&nbsp;</strong>is primarily a <strong>locally invasive tumor</strong> that <strong>rarely spreads</strong> via the lymphatic or hematogenous routes, distinguishing it from other more aggressive skin cancers.</span></p>",
    "correct_choice_id": 39313,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10427,
    "choices": [
      {
        "id": 41674,
        "text": "<p><span style=\"font-size:12.0pt;\">Turner syndrome</span></p>"
      },
      {
        "id": 41675,
        "text": "<p><span style=\"font-size:12.0pt;\">Down syndrome</span></p>"
      },
      {
        "id": 41676,
        "text": "<p><span style=\"font-size:12.0pt;\">Patau syndrome</span></p>"
      },
      {
        "id": 41677,
        "text": "<p><span style=\"font-size:12.0pt;\">Edward syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A girl presents with short stature, webbed neck, thick calves, shield -shaped chest, swelling of the ankle, and increased carrying angle. What is the likely diagnosis? (NEET PG 2021)</span></p>",
    "unique_key": "Q2880435",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578764,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Turner syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The constellation of symptoms including short stature, webbed neck, thick calves, shield-shaped chest, swelling of the ankles, and increased carrying angle is suggestive of Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome is caused by complete or partial X-chromosome monosomy. In phenotypic females, it causes hypogonadism. In females, it is the most common sex chromosome abnormality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important features associated with Turner's syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Short stature</span></li><li><span style=\"font-size:12.0pt;\">Webbing of neck</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Cubitus valgus</span></li><li><span style=\"font-size:12.0pt;\">Streak ovaries, infertility, amenorrhea</span></li><li><span style=\"font-size:12.0pt;\">Peripheral lymphedema at birth</span></li><li><span style=\"font-size:12.0pt;\">Low posterior hairline</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Pigmented nevi</span></li><li><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20195617.jpg\" width=\"440\" height=\"671\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Down syndrome: </strong>(Trisomy 21) is characterized by intellectual disability, facial dysmorphism, and increased risk of certain medical conditions such as congenital heart defects and leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Patau syndrome:&nbsp;</strong>(Trisomy 13): characterised by severe intellectual disability, cleft lip/palate, polydactyly, microcephaly, congenital heart defects, and often leads to early infant mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Edward syndrome:&nbsp;</strong>(Trisomy 18) characterised by severe intellectual disability, micrognathia (small jaw), clenched fists with overlapping fingers, rocker-bottom feet, congenital heart defects, and also typically results in early infant mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome is characterized by features such as short stature, webbed neck, shield-shaped chest, peripheral lymphedema, and increased carrying angle, among other physical manifestations. It is caused by complete or partial monosomy of the X chromosome in phenotypic females.</span></p>",
    "correct_choice_id": 41674,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10102,
    "choices": [
      {
        "id": 40374,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
      },
      {
        "id": 40375,
        "text": "<p><span style=\"font-size:12.0pt;\">Synovial sarcoma</span></p>"
      },
      {
        "id": 40376,
        "text": "<p><span style=\"font-size:12.0pt;\">Ewing sarcoma</span></p>"
      },
      {
        "id": 40377,
        "text": "<p><span style=\"font-size:12.0pt;\">Inflammatory myofibroblastic tumour</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">ALK positivity is seen in which of the following neoplasms: </span>(AIIMS MAY 2017)</p>",
    "unique_key": "Q6809770",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578787,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Inflammatory myofibroblastic tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALK (anaplastic lymphoma kinase) is seen in Inflammatory myofibroblastic tumor of lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(ALK) Anaplastic lymphoma kinase {<strong>CD246</strong>} is a tyrosine kinase receptor encoded by the ALK gene located on <strong>chromosome 2p</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALK positive tumors respond to ALK kinase inhibitors, therefore it has an <strong>excellent prognosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fibromatosis</strong>: ALK positivity is not associated with fibromatosis. This condition is characterized by fibroblastic proliferation, and ALK is not typically involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Synovial sarcoma</strong>: Synovial sarcoma does not show ALK positivity. It is more often associated with specific translocations, such as <strong>t(X;18)(p11;q11)</strong>, resulting in SS18-SSX fusion genes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ewing sarcoma</strong>: Ewing sarcoma is characterized by a specific <strong>EWSR1-FLI1 fusion gene</strong> due to a translocation involving chromosomes 11 and 22. ALK positivity is not seen in Ewing sarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ALK positivity is seen in:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lung Cancers \u2013 Adenocarcinoma</strong>, small cell cancer, anaplastic cancer</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inflammatory myofibroblastic tumor</strong></span></li><li><span style=\"font-size:12.0pt;\">Neuroblastoma</span></li><li><span style=\"font-size:12.0pt;\">Renal cell carcinomas</span></li><li><span style=\"font-size:12.0pt;\">Esophageal squamous cell carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Breast cancer notably the inflammatory subtype</span></li><li><span style=\"font-size:12.0pt;\">Colonic adenocarcinoma</span></li><li><span style=\"font-size:12.0pt;\">Glioblastoma multiforme</span></li><li><span style=\"font-size:12.0pt;\">Anaplastic thyroid cancer</span></li></ul>",
    "correct_choice_id": 40377,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 10489,
    "choices": [
      {
        "id": 41922,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Silica</span></span></span></p>"
      },
      {
        "id": 41923,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asbestos</span></span></span></p>"
      },
      {
        "id": 41924,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coal dust</span></span></span></p>"
      },
      {
        "id": 41925,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cotton</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person working in an industry for a long time developed progressive breathlessness. The histopathological image of his lung biopsy is given below. What industry was he most likely working in? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-386.jpg\" style=\"height:225px; width:300px\" /></span></span></p>",
    "unique_key": "Q3355578",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578789,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Asbestos</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">From the clinical history of progressive breathlessness and the histopathological image showing asbestos bodies, ferruginous bodies, and fibrosis, the patient is most likely working in the asbestos industry.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Asbestosis is a type of pneumoconiosis associated with asbestos exposure. The disease-causing capabilities of the different forms of asbestos depend on concentration, size, shape, and solubility. This condition is marked by diffuse pulmonary interstitial fibrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grossly,</span></strong><span style=\"font-size:12.0pt\"> the affected lungs are small and firm with <strong>cartilage-like thickening of the pleura</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-387.jpg\" style=\"height:541px; width:271px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The sectioned surface shows variable degree of pulmonary fibrosis, especially in the subpleural areas and in the bases of lungs. The advanced cases may show cystic changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-388.jpg\" style=\"height:336px; width:336px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gross appearance of the lung in asbestosis diagram</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Histologically, the following changes are observed:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There is non-specific interstitial fibrosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There is presence of characteristic asbestos bodies in the involved areas. These are asbestos fibres coated with glycoprotein and haemosiderin and appear beaded or dumbbell-shaped. The coating stains positively for Prussian blue reaction. Similar iron-protein complexes coat other inorganic particulates other than asbestos which are termed as ferruginous bodies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Microscopic appearance of asbestos body. An asbestos body is an asbestos fibre coated with glycoprotein and haemosiderin giving it beaded or dumbbell-shaped appearance with bulbous ends. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note: Asbestos exposure is associated with malignant mesothelioma.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Silica</span></strong><span style=\"font-size:12.0pt\">: Silica exposure leads to silicosis, which is characterized by nodular fibrosis, not asbestos bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Coal dust</span></strong><span style=\"font-size:12.0pt\">: Coal dust exposure leads to coal workers&#39; pneumoconiosis (CWP) or &quot;black lung disease,&quot; characterized by coal macules and nodules in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cotton</span></strong><span style=\"font-size:12.0pt\">: Cotton dust exposure leads to byssinosis, which is primarily associated with respiratory symptoms but does not cause the fibrosis and asbestos bodies seen in asbestosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Asbestosis&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is associated with the presence of <strong>asbestos bodies</strong> and interstitial fibrosis, typically seen in individuals working in industries involving <strong>asbestos exposure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition 1306-1307</span></strong></span></span></p>",
    "correct_choice_id": 41923,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10459,
    "choices": [
      {
        "id": 41802,
        "text": "<p><span style=\"font-size:12.0pt;\">It is detected in blood during sepsis</span></p>"
      },
      {
        "id": 41803,
        "text": "<p><span style=\"font-size:12.0pt;\">It is produced in response to bacterial infection.</span></p>"
      },
      {
        "id": 41804,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial DNA is seen.</span></p>"
      },
      {
        "id": 41805,
        "text": "<p><span style=\"font-size:12.0pt;\">It is chromatin with antibacterial enzymes.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is false regarding neutrophil extracellular trapping (NET)? (NEET PG 2022)</span></p>",
    "unique_key": "Q4655325",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578778,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Mitochondrial DNA is seen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitochondrial DNA is not seen in neutrophil extracellular traps (NET). In classic NETosis, the DNA is nuclear, not mitochondrial.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some rare reports suggest that under certain non-lytic forms, mitochondrial DNA may be extruded, but this is not typical of NETs as understood in bacterial infections or sepsis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neutrophilic extracellular traps (NET) are a network of neutrophil nuclear chromatin/DNA. The death of neutrophils is caused by the loss of nuclei. They assemble antimicrobial peptides and enzymes to combat bacteria and fungi (not viruses). During sepsis, they are detected in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are produced by neutrophils in response to:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Infectious pathogens: mainly bacteria and fungi</span></li><li><span style=\"font-size:12.0pt;\">Inflammatory mediators: chemokines, cytokines (mainly interferons), complement proteins, and reactive oxygen species (ROS)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is detected in blood during sepsis</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>True Statement:</strong> NETs are indeed detected in the blood during sepsis as part of the body's response to widespread infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is produced in response to bacterial infection</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>True Statement:</strong> NETs are produced in response to bacterial infection as well as fungal infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is chromatin with antibacterial enzymes</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>True Statement:</strong> NETs consist of chromatin (DNA) along with antibacterial enzymes and peptides, which help in trapping and killing pathogens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neutrophil extracellular traps (NETs) are networks of nuclear DNA from neutrophils combined with antimicrobial enzymes and peptides, produced in response to bacterial and fungal infections. They play a crucial role in trapping and neutralizing pathogens. The presence of mitochondrial DNA in NETs is incorrect, as NETs are composed of nuclear chromatin.</span></p>",
    "correct_choice_id": 41804,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10104,
    "choices": [
      {
        "id": 40382,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</span></p>"
      },
      {
        "id": 40383,
        "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</span></p>"
      },
      {
        "id": 40384,
        "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron responsive elements decreases transferrin receptor mRNA concentration and synthesis</span></p>"
      },
      {
        "id": 40385,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron responsive element decreases and ferritin synthesis increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding the internal iron homeostasis in iron-deficiency anemia? </span>(AIIMS MAY 2017)</p>",
    "unique_key": "Q1807567",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578788,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)</strong> <strong>Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In iron deficiency anemia, there is an increase in transferrin receptor mRNA concentration and synthesis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155.png\" alt=\"\" width=\"1000\" height=\"277\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high. Low serum iron with increased iron-binding capacity results in a reduction of transferrin saturation to below 15%. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</strong>: This statement is incorrect. In iron deficiency, ferritin synthesis decreases as the body conserves iron, but the ferritin mRNA concentration does not increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Transferrin receptor 1 iron-responsive elements decreases transferrin receptor mRNA concentration and synthesis</strong>: This is incorrect because in iron deficiency, transferrin receptor 1 expression increases to maximize iron uptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ferritin mRNA concentration iron-responsive element decreases and ferritin synthesis increases</strong>: This is also incorrect. In iron deficiency, both ferritin mRNA levels and ferritin synthesis decrease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In iron-deficiency anemia, transferrin receptor 1 iron-responsive elements increase mRNA concentration and synthesis to enhance iron uptake, while ferritin levels decrease as the body attempts to conserve iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, pg 1231-1234</strong></span></p>",
    "correct_choice_id": 40383,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 32303,
    "choices": [
      {
        "id": 129070,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 129071,
        "text": "<p><span style=\"font-size:12.0pt;\">Prostate cancer</span></p>"
      },
      {
        "id": 129072,
        "text": "<p><span style=\"font-size:12.0pt;\">Potts spine</span></p>"
      },
      {
        "id": 129073,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old with lower backache had low hemoglobin, increased creatinine and multiple osteolytic lesions on radiograph. His serum electrophoresis revealed normal albumin but disproportionately high globulin. What is the likely diagnosis in this patient? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q2340848",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578758,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Multiple myeloma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The clinical picture presented is suggestive of anemia, renal dysfunction and bony lytic lesions with increased production of globulin levels suggestive of monoclonal proliferation of plasma cells and meeting the CRAB criteria of multiple myeloma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-161816.jpg\" alt=\"\" width=\"1000\" height=\"422\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prostate cancer</strong>: Prostate cancer can present with bone pain due to metastasis, but it typically causes sclerotic (rather than osteolytic) bone lesions and does not cause the marked increase in globulin levels seen in multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pott's spine</strong>: This refers to tuberculosis of the spine and can present with back pain and osteolytic lesions, but it is not associated with increased globulin levels or the hematological findings seen in multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Osteoporosis</strong>: Osteoporosis can cause bone pain and fractures but does not cause anemia, renal dysfunction, or increased globulin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>: &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Multiple myeloma is characterized by anemia, renal dysfunction, osteolytic bone lesions, and a high globulin level due to monoclonal proliferation of plasma cells.</span></p>",
    "correct_choice_id": 129070,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 10010,
    "choices": [
      {
        "id": 40006,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenocarcinoma</span></span></span></p>"
      },
      {
        "id": 40007,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
      },
      {
        "id": 40008,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Large cell carcinoma</span></span></span></p>"
      },
      {
        "id": 40009,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell carcinoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male, with a smoking history of 20 pack years, presented in OPD with breathlessness and chest pain. Further investigations revealed a lung tumor. On staining, cells are positive for chromogranin. What is the likely diagnosis? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2022)</span></span></p>",
    "unique_key": "Q9873234",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578738,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Small cell carcinoma&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of chronic smoking and lung tumor cells staining positive for chromogranin suggests small cell carcinoma of the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SMALL CELL CARCINOMAS:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This highly malignant tumor has a distinctive cell type. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strongly associated with cigarette smoking</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This lung cancer type is most commonly associated with ectopic hormone production</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Electron microscopy shows </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dense-core neurosecretory granules are present along the bronchial epithelium which can secrete polypeptide hormones</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of neuroendocrine markers such as chromogranin, synaptophysin, and CD57 (in 75% of cases) and parathormone-like and other hormonally active products suggest derivation of this tumor from neuroendocrine progenitor cells of the lining bronchial epithelium. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Adenocarcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is the most common subtype of lung cancer, especially in non-smokers, and it typically involves peripheral lung lesions. It is characterized by markers like TTF-1, NAPSIN-A, and CEA, rather than chromogranin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Squamous cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type is also associated with smoking but is more likely to present centrally in the lungs. It shows keratinization and intercellular bridges on histology and is associated with markers like p40 and p63, not chromogranin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Large cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This diagnosis is typically a diagnosis of exclusion and does not have a specific marker like chromogranin. It is also more common in non-smokers and presents as a peripheral tumor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311.jpg\" style=\"height:733px; width:800px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-144842.jpg\" style=\"height:658px; width:1000px\" /></span></span></span></span></p>",
    "correct_choice_id": 40009,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 10365,
    "choices": [
      {
        "id": 41426,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myxoid liposarcoma</span></span></span></p>"
      },
      {
        "id": 41427,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lipoma</span></span></span></p>"
      },
      {
        "id": 41428,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spindle lipoma</span></span></span></p>"
      },
      {
        "id": 41429,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polymorphic lipoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presented with a retroperitoneal mass. Biopsy from the lesion is shown in the image below. Molecular analysis revealed t(12;16). What is the most likely condition? (NEET PG 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-398.jpg\" style=\"height:261px; width:400px\" /></p>",
    "unique_key": "Q3813138",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578792,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Myxoid liposarcoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario is suggestive of <strong>myxoid liposarcoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows a <strong>lot of ground substance, as well as some branching capillaries and immature adipocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liposarcoma is the most common sarcoma in adults, typically appearing in <strong>the fifth to sixth decade of life.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are most commonly found in the <strong>proximal extremities (deep soft tissues</strong>) and the retroperitoneum.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically the liposarcomas are divided into four subtypes:&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Well-differentiated liposarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: resembles lipoma but contains uni- or multi-vacuolated lipoblasts. It is associated with <strong>amplification of 12q13-g15.</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myxoid liposarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Most common histologic type. It is composed of monomorphic, fusiform or stellate cells representing primitive mesenchymal cells, lying dispersed in mucopolysaccharide-rich ground substance. Occasional tumor giant cells may be present. Prominent meshwork of capillaries forming chicken-wire patterns is a conspicuous feature. It is associated with <strong>t (12;16).</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Round cell liposarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is composed of uniform, round to oval cells having fine multi vacuolated cytoplasm with central hyperchromatic nuclei. Round cell liposarcoma may resemble a <strong><em>signet-ring carcinoma</em></strong> but mucin stains help in distinguishing the two.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pleomorphic liposarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> highly undifferentiated and the most anaplastic type. There are numerous large tumor giant cells and bizarre lipoblasts.&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Lipomas are benign tumors of adipose tissue and do not show the histological features or molecular translocation (t (12;16)) seen in myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Spindle lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Spindle cell lipomas are benign tumors composed of spindle-shaped cells mixed with mature adipocytes and do not have the mucopolysaccharide-rich ground substance or the t (12;16) translocation seen in myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Polymorphic lipoma:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Polymorphic lipomas are also benign and do not exhibit the characteristic histological features or molecular markers of myxoid liposarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myxoid liposarcoma is the most common histologic type of liposarcoma, characterized by a mucopolysaccharide-rich ground substance, a prominent capillary network forming chicken-wire patterns, and the presence of the translocation t (12;16).</span></span></span></p>",
    "correct_choice_id": 41426,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 65188,
    "choices": [
      {
        "id": 259929,
        "text": "<p><span style=\"font-size:12.0pt;\">Mast cells</span></p>"
      },
      {
        "id": 259930,
        "text": "<p><span style=\"font-size:12.0pt;\">Eosinophils</span></p>"
      },
      {
        "id": 259931,
        "text": "<p><span style=\"font-size:12.0pt;\">IgE</span></p>"
      },
      {
        "id": 259932,
        "text": "<p><span style=\"font-size:12.0pt;\">Neutrophils</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old woman presents annually with recurrent episodes of wheezing, cough, and difficulty breathing during a specific season. She has a history of seasonal allergies and reports exacerbations triggered by pollen exposure. Laboratory tests show elevated serum IgE levels, and she experiences rapid onset of symptoms shortly after exposure to the allergen. Which of the following cells is primarily responsible for the acute symptoms observed in this patient? (Twisted PYQ)</span></p>",
    "unique_key": "Q9049549",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578745,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mast cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient\u2019s symptoms are characteristic of <strong>seasonal allergic asthma</strong>, which is a type I hypersensitivity reaction. The key feature here is the <strong>rapid onset of symptoms</strong> (wheezing, cough, and shortness of breath) shortly after exposure to an allergen (e.g., pollen), which points to an <strong>immediate-type hypersensitivity</strong> reaction. In this type of allergic reaction, <strong>mast cells</strong> play a central role.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Mast cells</strong> (Option A) are the <strong>primary effector cells</strong> in <strong>Type I hypersensitivity</strong> reactions. When the patient\u2019s <strong>IgE</strong> (Option C) binds to mast cells, it sensitizes them. Upon subsequent exposure to the allergen, mast cells degranulate and release histamine and other mediators that cause the acute symptoms (such as bronchoconstriction and mucosal inflammation).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Eosinophils</strong> (Option B) are involved in the <strong>late-phase</strong> inflammatory response (the <strong>chronic phase</strong>) of asthma and allergies, but they are not responsible for the <strong>acute symptoms</strong> in this case.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IgE</strong> (Option C) is critical in sensitizing mast cells but does not directly cause the symptoms itself. It binds to mast cells, and when the allergen interacts with the IgE, it triggers mast cell degranulation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neutrophils</strong> (Option D) are involved in <strong>Type III hypersensitivity reactions</strong> and infections, but they are not central to the allergic responses seen in asthma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In <strong>Type I hypersensitivity</strong> reactions (like allergic asthma), <strong>mast cells</strong> are the key players responsible for the <strong>acute</strong> symptoms, with <strong>IgE</strong> being crucial for mast cell sensitization.</span></p><p>&nbsp;</p><p><img class=\"image_resized\" style=\"aspect-ratio:532/621;width:100%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/3.png\" width=\"532\" height=\"621\"></p>",
    "correct_choice_id": 259929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 10067,
    "choices": [
      {
        "id": 40234,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatitis C virus</span></span></span></p>"
      },
      {
        "id": 40235,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dengue virus</span></span></span></p>"
      },
      {
        "id": 40236,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Human immunodeficiency virus</span></span></span></p>"
      },
      {
        "id": 40237,
        "text": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatitis B virus</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Donor blood should be screened for the following infections except: (INICET MAY 2022)</span></span></p>",
    "unique_key": "Q9334966",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578774,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Dengue virus</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dengue virus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not typically included in the mandatory screening process for blood donations. While dengue is a significant public health issue, particularly in tropical and subtropical regions, its transmission through blood transfusion is rare and not considered a primary risk compared to the other pathogens listed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Hepatitis C virus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This virus is a common cause of liver disease and is a bloodborne pathogen. Blood donations are routinely screened for HCV to prevent transmission through transfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Human immunodeficiency virus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: HIV is a critical pathogen to screen for in donated blood because it can be transmitted through blood transfusion and is responsible for causing AIDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hepatitis B virus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Like HCV, HBV is a major bloodborne pathogen that can lead to serious liver disease. Blood is routinely screened for HBV to ensure it is safe for transfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donor blood require screening for infectious disease pathogen:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis C virus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Human immunodeficiency virus (HIV)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis B virus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malaria&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Syphilis.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 40235,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 43948,
    "choices": [
      {
        "id": 175455,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti GBM antibody</span></p>"
      },
      {
        "id": 175456,
        "text": "<p><span style=\"font-size:12.0pt;\">ANCA</span></p>"
      },
      {
        "id": 175457,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti phospholipase A2 receptor antibody</span></p>"
      },
      {
        "id": 175458,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti nuclear antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old male presents with 400 ml urine output in 24 hours. On histology he had crescents with pauci immune glomerulonephritis. What is the main etiology?&nbsp;(INICET NOV 2023)</span></p>",
    "unique_key": "Q6114365",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578752,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) ANCA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of crescents in a pauci-immune glomerulonephritis pattern is characteristic of ANCA-associated vasculitis. This type of vasculitis does not typically involve immune deposits (hence \"pauci-immune\") and is commonly associated with anti-neutrophil cytoplasmic antibodies (ANCA). These antibodies are directed against constituents of neutrophil granules and monocyte lysosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti GBM antibody:&nbsp;</strong>This antibody targets the glomerular basement membrane, leading to Goodpasture's syndrome, which is typically not pauci-immune.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-phospholipase A2 receptor antibody</strong>: This is primarily associated with primary membranous nephropathy, which shows a different histological pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti-nuclear antibody</strong>: While antinuclear antibodies (ANA) are associated with systemic lupus erythematosus, which can involve the kidneys, lupus nephritis usually shows immune complex deposition, unlike pauci-immune glomerulonephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ANCA-associated vasculitis is linked to pauci-immune glomerulonephritis, where crescents are formed in glomeruli without significant immune deposits, differentiating it from conditions such as Goodpasture's syndrome or lupus nephritis.</span></p>",
    "correct_choice_id": 175456,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 14628,
    "choices": [
      {
        "id": 58473,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Goodpasture syndrome </span></span></span></p>"
      },
      {
        "id": 58474,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glomerular nephropathy </span></span></span></p>"
      },
      {
        "id": 58475,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 58476,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alport&rsquo;s syndrome</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year old male patient is presenting with hematuria and hemoptysis. On further testing Anti glomerular basement membrane antibody is positive, what will be the diagnosis? (FMGE JAN 2023)</span></span></p>",
    "unique_key": "Q1485775",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578746,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) &nbsp;Goodpasture syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given clinical scenario is suggestive of good pasture syndrome as patient is presenting with <strong>hematuria and hemoptysis</strong> along with Anti glomerular basement membrane antibody. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is <strong>type 2 hypersensitivity</strong> reaction</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It belongs to <strong>type 1 RPGN</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The autoantibodies are directed against the <strong>alpha 3 chain of collagen IV</strong> and predominantly belong to the IgG group. This immunofluorescence pattern shows positivity with antibody to IgG and has a&nbsp;<strong>smooth, diffuse, linear pattern</strong>&nbsp;that is characteristic for deposition of glomerular basement membrane antibody with Goodpasture syndrome. Serologic testing for anti-GBM in patient serum is often positive.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-25-191628.jpg\" style=\"height:355px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glomerular nephropathy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a general term for diseases affecting the glomeruli, but it does not specifically fit the provided clinical scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While Goodpasture syndrome is a type of glomerulonephritis, the specific presence of anti-GBM antibodies and the combination of hematuria and hemoptysis point directly to Goodpasture syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alport&rsquo;s syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a genetic disorder characterized by glomerulonephritis, end-stage kidney disease, and hearing loss, and it does not typically present with anti-GBM antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture syndrome is characterized by the presence of anti-glomerular basement membrane antibodies, hematuria, and hemoptysis, and is a type II hypersensitivity reaction associated with type I Rapidly Progressive Glomerulonephritis (RPGN).</span></span></span></p>",
    "correct_choice_id": 58473,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ]
  },
  {
    "id": 47536,
    "choices": [
      {
        "id": 189755,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous Cell Carcinoma</span></p>"
      },
      {
        "id": 189756,
        "text": "<p><span style=\"font-size:12.0pt;\">Basal Cell Carcinoma</span></p>"
      },
      {
        "id": 189757,
        "text": "<p><span style=\"font-size:12.0pt;\">Molluscum contagiosum</span></p>"
      },
      {
        "id": 189758,
        "text": "<p><span style=\"font-size:12.0pt;\">Verrucous carcinoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A farmer had a lesion on his shoulder. Histopathological image of the lesion is shown below. Identify the diagnosis:&nbsp;</span>(FMGE JANUARY 2024)</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-152657.png\" alt=\"\" width=\"500\" height=\"361\"></span></p>",
    "unique_key": "Q5344737",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578760,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Squamous Cell Carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The histopathological image provided shows features consistent with squamous cell carcinoma (SCC). The key characteristics that support this diagnosis are the presence of keratin pearls and intercellular bridges.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Keratin pearls</strong> are concentric, whorl-like structures composed of keratinized cells, which are a hallmark of well-differentiated SCC. The presence of keratin indicates that the tumor cells are undergoing a process of keratinization, which is a characteristic feature of squamous epithelium. In the image, the pink, circular structures with a laminated appearance are keratin pearls.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intercellular bridges, also known as <strong>desmosomes</strong>, are specialized cell junctions that connect adjacent squamous epithelial cells. These bridges help maintain the structural integrity of the epithelium and are visible as small, spiky projections between the tumor cells in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The occupation of the patient (farmer) is also relevant, as prolonged exposure to ultraviolet (UV) radiation from sunlight is a major risk factor for the development of SCC, particularly on sun-exposed areas like the shoulder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Basal Cell Carcinoma:&nbsp;</strong>Basal cell carcinoma (BCC) is another type of skin cancer that arises from the basal layer of the epidermis. However, BCC typically lacks keratinization and the formation of keratin pearls, which are seen in this image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Molluscum contagiosum:&nbsp;</strong>Molluscum contagiosum is a viral skin infection caused by a poxvirus. Histologically, it is characterized by the presence of molluscum bodies, which are large, eosinophilic, intracytoplasmic inclusions within the keratinocytes. These features are not seen in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verrucous carcinoma:&nbsp;</strong>Verrucous carcinoma is a rare, low-grade variant of SCC that typically presents as a warty, exophytic growth. While it may show some keratinization, the classic keratin pearls and intercellular bridges seen in this image are more suggestive of conventional SCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of keratin pearls and intercellular bridges in a skin biopsy is highly suggestive of squamous cell carcinoma, particularly in a patient with a history of prolonged sun exposure.</span></p>",
    "correct_choice_id": 189755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ]
  },
  {
    "id": 47738,
    "choices": [
      {
        "id": 190559,
        "text": "<p><span style=\"font-size:12.0pt;\">X-linked inheritance&nbsp;</span></p>"
      },
      {
        "id": 190560,
        "text": "<p><span style=\"font-size:12.0pt;\">More severe in males&nbsp;</span></p>"
      },
      {
        "id": 190561,
        "text": "<p><span style=\"font-size:12.0pt;\">Contradicts the Lyon Hypothesis&nbsp;</span></p>"
      },
      {
        "id": 190562,
        "text": "<p><span style=\"font-size:12.0pt;\">May affect heterozygous females</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about the genetics of G6PD Deficiency is incorrect? (NEET PG 2015)</span></p>",
    "unique_key": "Q8228767",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578762,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. Contradicts the Lyon Hypothesis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD deficiency follows an X-linked inheritance pattern, with the gene located on the X chromosome. The Lyon hypothesis (X-chromosome inactivation) actually explains why some heterozygous females can be affected by G6PD deficiency, though typically less severely than males. During early embryonic development, one X chromosome in each female cell is randomly inactivated. If a higher proportion of cells have the normal X chromosome inactivated, these females can express symptoms of G6PD deficiency. This variable inactivation creates a mosaic pattern in heterozygous females rather than contradicting the hypothesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. X-linked inheritance</strong> - This is correct. G6PD deficiency is indeed an X-linked recessive disorder, which places males at much higher risk for symptomatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. More severe in males</strong> - This is correct. Since males have only one X chromosome, if they inherit the defective G6PD gene, they will express the disorder fully, making the condition typically more severe in males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. May affect heterozygous females</strong> - This is correct. Heterozygous females can be affected due to random X-inactivation, where some cells express the defective G6PD gene, potentially leading to clinical manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD deficiency is an X-linked recessive disorder that follows the principles of the Lyon hypothesis, with males being more severely affected, while heterozygous females may show variable expression depending on X-chromosome inactivation patterns.</span></p>",
    "correct_choice_id": 190561,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 9802,
    "choices": [
      {
        "id": 39175,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
      },
      {
        "id": 39176,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Post-streptococcal glomerulonephritis (PSG)</span></span></span></p>"
      },
      {
        "id": 39177,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Good pasture syndrome</span></span></span></p>"
      },
      {
        "id": 39178,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A middle-aged male patient has proteinuria. Looking at the immunofluorescence image below, what is the diagnosis? (AIIMS NOV 2018)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/946.jpg\" style=\"height:217px; width:500px\" /></span></span></span></p>",
    "unique_key": "Q6612801",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578768,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given immunofluorescence staining of the kidney biopsy specimen shows positive staining for fibrinogen, IgG, IgA, IgM, C1q, C3, &lambda; chain, and k light chain. This is <strong>known as full-house effect</strong>. It is seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Six patterns of lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I - Minimal lesions - deposits within the <u>mesangium p</u>ositive for IgG and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II &ndash; Mesangial lupus nephritis - Granular <u>mesangial deposits </u>of IgG and C3; sometimes IgA and IgM are also present in the deposits.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III &ndash; Focal segmental lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Subendothelial and subepithelial deposits of IgG, often with IgM or IgA and C3, are seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV &ndash; Diffuse lupus nephritis </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&ndash; <strong>Most severe and most common</strong>. Deposits in the mesangium and in the <strong>subendothelial region</strong> which on immunofluorescence are positive for IgG; sometimes also for IgA or IgM, and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class V &ndash; Membranous Lupus Nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>subendothelial</strong> deposits of immune complexes containing IgG, IgM and C3</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class VI &ndash; Sclerosing Lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - End-stage kidney of SLE. Most glomeruli are sclerosed and hyalinised and there may be remnants of preceding lesions.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Focal segmental glomerulosclerosis (FSGS)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This does not typically show a full-house pattern on immunofluorescence. FSGS is usually characterized by segmental glomerular scarring and may show focal deposits of IgM and C3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Post-streptococcal glomerulonephritis (PSG)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition typically shows deposits of IgG and C3 in a &quot;starry sky&quot; pattern on immunofluorescence but does not display a full-house pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Goodpasture syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This typically shows linear deposits of IgG along the glomerular basement membrane, without the full-house pattern seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>full-house effect</strong> on immunofluorescence (positive staining for IgG, IgA, IgM, C1q, C3, &lambda; chain, and &kappa; light chain) is a hallmark of <strong>lupus nephritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins Pathologic basis of disease 8<sup>th</sup> edition, Pg 409-410</span></strong></span></span></p>",
    "correct_choice_id": 39178,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 65189,
    "choices": [
      {
        "id": 259933,
        "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
      },
      {
        "id": 259934,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
      },
      {
        "id": 259935,
        "text": "<p><span style=\"font-size:12.0pt;\">X-linked dominant</span></p>"
      },
      {
        "id": 259936,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An affected male does not have affected children, but 50% of the offspring of an affected female are affected. Which of the following is the likely pattern of inheritance in the given situation. (Twisted PYQ)</span></p>",
    "unique_key": "Q4696344",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578753,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) X-linked recessive</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">X-linked recessive inheritance is a pattern in which a gene located on the X chromosome causes a condition that can affect both males and females. The distinguishing feature of X-linked recessive inheritance is that affected males cannot pass the trait to their sons (since males pass only the Y chromosome to their sons), but they pass it to all of their daughters making them carriers. However an affected female is going to have both the genes defective and shall have all her sons having the disease and all her daughters acting as carriers..</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Autosomal recessive</strong>: Incorrect. Autosomal recessive conditions require both parents to pass on a copy of the mutated gene, leading to equal chances of affecting both sexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. X-linked dominant:</strong> Incorrect. Affected males pass the condition to all daughters but not to their sons.&nbsp;Affected females pass the condition to 50% of their offspring (both sons and daughters).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Mitochondrial</strong>: Incorrect. Mitochondrial inheritance is characterized by maternal transmission, where affected males do not pass the trait, but all offspring of affected females inherit it.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In X-linked recessive inheritance, males are more frequently affected, and females are typically carriers. Affected males do not pass the condition to their sons, but daughters may become carriers.</span></p>",
    "correct_choice_id": 259933,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 32304,
    "choices": [
      {
        "id": 129074,
        "text": "<p><span style=\"font-size:12.0pt;\">History of radiation exposure</span></p>"
      },
      {
        "id": 129075,
        "text": "<p><span style=\"font-size:12.0pt;\">Affects in early third decade</span></p>"
      },
      {
        "id": 129076,
        "text": "<p><span style=\"font-size:12.0pt;\">Tests reveals elevated serum calcitonin levels</span></p>"
      },
      {
        "id": 129077,
        "text": "<p><span style=\"font-size:12.0pt;\">Most patients have a good prognosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not the correct statement about papillary thyroid cancer? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q9043312",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578761,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Tests reveals elevated serum calcitonin levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Papillary thyroid cancer (PTC) is the most common type of thyroid cancer and generally has a good prognosis. It is often associated with a history of radiation exposure, and it commonly affects individuals in their early third decade (20s-30s). However, elevated serum calcitonin levels are not a feature of PTC; this finding is specific to medullary thyroid cancer (MTC), which arises from the parafollicular cells (C cells) of the thyroid and produces calcitonin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. History of radiation exposure</strong>: This is a known risk factor for the development of PTC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Affects in early third decade</strong>: PTC commonly presents in young adults, particularly in the third decade of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Most patients have a good prognosis</strong>: PTC generally has an excellent prognosis, especially when diagnosed early and treated appropriately.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Papillary thyroid cancer is not associated with elevated serum calcitonin levels; this is a characteristic feature of medullary thyroid cancer.</span></p>",
    "correct_choice_id": 129076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 9835,
    "choices": [
      {
        "id": 39307,
        "text": "<p><span style=\"font-size:12.0pt;\">Lipids without MHC proteins</span></p>"
      },
      {
        "id": 39308,
        "text": "<p><span style=\"font-size:12.0pt;\">Peptides with MHC proteins</span></p>"
      },
      {
        "id": 39309,
        "text": "<p><span style=\"font-size:12.0pt;\">CD20</span></p>"
      },
      {
        "id": 39310,
        "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Gamma delta T cell receptors (\u03b3\u03b4 TCRs) recognizes? </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q2851723",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578782,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Lipids without MHC proteins</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A small population of mature T cells expresses a type of TCR composed of \u03b3 and \u03b4 polypeptide chains. <strong>The \u03b3\u03b4 TCR recognizes peptides, lipids, and small molecules, without a requirement for display by MHC proteins</strong>. \u03b3\u03b4 T cells tend to aggregate at epithelial surfaces, such as the skin and mucosa of the gastrointestinal and urogenital tracts, suggesting that these cells are sentinels that protect against microbes that try to enter through epithelia</span></li><li><span style=\"font-size:12.0pt;\"><strong>The \u03b1\u03b2 TCR recognizes peptide antigens that are displayed by major histocompatibility complex (MHC. molecules on the surfaces of antigen-presenting cells (APCs).</strong> By limiting the specificity of T cells for peptides displayed by cell surface MHC molecules, <strong>called MHC restriction</strong>, the immune system ensures that T cells see only cell-associated antigens (e.g., those derived from microbes in cells).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Peptides with MHC proteins</strong>: This is characteristic of <strong>\u03b1\u03b2 TCRs</strong>, not \u03b3\u03b4 TCRs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD20</strong>: CD20 is a B cell marker, not a target recognized by T cell receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CD3</strong>: CD3 is a signaling molecule associated with the T cell receptor complex but is not a specific target recognized by the TCR itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gamma delta T cell receptors (\u03b3\u03b4 TCRs)&nbsp;</strong>are unique in that they can recognize <strong>lipids and other molecules without the need for MHC protein presentation</strong>, distinguishing them from the more common \u03b1\u03b2 T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8th edition pg 353</strong></span></p>",
    "correct_choice_id": 39307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10008,
    "choices": [
      {
        "id": 39998,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary cancer of thyroid</span></span></span></p>"
      },
      {
        "id": 39999,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Follicular cancer of thyroid</span></span></span></p>"
      },
      {
        "id": 40000,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroglossal cyst</span></span></span></p>"
      },
      {
        "id": 40001,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papillary cancer of thyroid</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 19-year-old girl presents with a midline neck swelling that moves on deglutition. Ultrasound revealed a 2 cm x 2 cm nodule on the left lobe of the thyroid, extending into the strap muscles. The histopathology image is given below. What is the most likely diagnosis?&nbsp;(INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/5_PlzqSOh.jpg\" style=\"height:147px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q4201532",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578737,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Papillary cancer of thyroid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical scenario and the image showing papillae lined by cells with overlapping nuclei and Orphan Annie eye nuclei indicate a diagnosis of papillary carcinoma of thyroid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically, the following features are present</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary pattern - Papillae composed of fibrovascular stalk and covered by single layer of tumor cells is the predominant feature. Papillae are often accompanied by follicles.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor cells. The tumor cells have characteristic nuclear features due to dispersed nuclear chromatin imparting it ground glass or optically clear appearance and clear or oxyphilic cytoplasm also called Orphan Annie nuclei. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Invasion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Invade the capsule and intra-thyroid lymphatics</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psammoma bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Small, concentric, calcified spherules called psammoma bodies in the stroma.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma thyroid microscopy shows branching papillae having fibrovascular stalk covered by a single layer of cuboidal cells having ground nuclei. Colloid-filled follicles and sloid sheets of tumor cells are present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Medullary cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This cancer arises from the parafollicular C-cells of the thyroid and is associated with elevated calcitonin levels. Histologically, it shows a solid growth pattern with amyloid deposits, which is not seen in the provided image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Follicular cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type of thyroid cancer typically shows a follicular growth pattern with invasion into blood vessels or the capsule. The cells do not have the distinct nuclear features (Orphan Annie nuclei) seen in papillary carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Thyroglossal cyst</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a benign cystic lesion that usually presents as a midline neck mass that moves with swallowing or tongue protrusion. It does not present with a nodule in the thyroid gland or the histological features described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma of the thyroid is characterized by Orphan Annie nuclei, psammoma bodies, and a papillary architecture, which are key diagnostic features.</span></span></span></p>",
    "correct_choice_id": 40001,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9814,
    "choices": [
      {
        "id": 39223,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bare lymphocytes</span></span></span></p>"
      },
      {
        "id": 39224,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic granulocyte deficiency</span></span></span></p>"
      },
      {
        "id": 39225,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyper IgM syndrome</span></span></span></p>"
      },
      {
        "id": 39226,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DiGeorge syndrome</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 3-year-old boy presents with recurrent bacterial infections and Pneumocystis jiroveci pneumonia. The flowcytometry analysis of the boy (Boxes c &amp; d) is shown below (Boxes a &amp; b are normal). What is the most likely diagnosis?</span> </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2019)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/953.jpg\" style=\"height:507px; width:500px\" /></span></span></span></p>",
    "unique_key": "Q5423389",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578776,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hyper IgM syndrome</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario and the flow cytometry is suggestive of <strong>Hyper IgM syndrome</strong>. The flow cytometry shows the following findings:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B-cell gating (images a and c)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Side scatter (images b and d)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in the number of CD40 (image d)</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In hyper-IgM syndrome the affected patients make IgM antibodies but are deficient in their ability to produce IgG, IgA, and IgE antibodies<strong>. The ability of helper T cells to deliver activating signals to B cells and macrophages is affected.</strong> Many of the functions of CD4+ helper T cells require the engagement of CD40 on B cells, macrophages and dendritic cells by CD40L (also called CD154) expressed on antigen-activated T cells<strong>. This interaction triggers Ig class switching</strong> and affinity maturation in B cells, and stimulates the microbicidal functions of macrophages.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most of these patients have mutations in the gene encoding CD40 or the enzyme called activation-induced deaminase, a DNA-editing cytosine deaminase that is required for class switching and affinity maturation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/954.jpg\" style=\"height:418px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Bare lymphocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This refers to a rare genetic condition where major histocompatibility complex (MHC) molecules are not expressed on the surface of cells, leading to immune deficiency. This condition is unrelated to the findings presented in the question.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Chronic granulocyte deficiency</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This refers to Chronic Granulomatous Disease (CGD), a condition where phagocytes cannot effectively kill certain bacteria and fungi. It does not fit the flow cytometry or clinical presentation described in the question.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DiGeorge syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: DiGeorge syndrome is a congenital immunodeficiency due to the deletion of chromosome 22q11.2, leading to thymic hypoplasia and T cell deficiency. The clinical and flow cytometry findings in this question do not match those typically seen in DiGeorge syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyper IgM syndrome is characterized by a deficiency in class switching due to defective CD40-CD40L interactions, leading to elevated levels of IgM and a lack of other immunoglobulin isotypes.</span></span></span></p>",
    "correct_choice_id": 39225,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9961,
    "choices": [
      {
        "id": 39810,
        "text": "<p><span style=\"font-size:12.0pt;\">Renal amyloidosis</span></p>"
      },
      {
        "id": 39811,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
      },
      {
        "id": 39812,
        "text": "<p><span style=\"font-size:12.0pt;\">Kimmelstiel-Wilson disease</span></p>"
      },
      {
        "id": 39813,
        "text": "<p><span style=\"font-size:12.0pt;\">Lupus nephritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man presented with the blurring of vision. Urine examination showed proteinuria. Fundus examination showed dot and blot hemorrhages, microaneurysms, and cotton wool spots. Histopathology of the kidney was as shown below. What is your diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/31.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p>",
    "unique_key": "Q1136043",
    "question_audio": null,
    "question_video": null,
    "map_id": 34578781,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Kimmelstiel-Wilson disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological image shows <strong>acellular periodic acid Schiff (PAS)-positive nodules</strong> suggestive of nodular glomerulosclerosis/intercapillary glomerulosclerosis seen in <strong>Kimmelstiel Wilson disease,</strong> which occurs in patients with diabetic nephropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These lesions are <strong>specific for type 1 diabetes</strong> (juvenile onset diabetes) or islet cell antibody-positive diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pathologic changes consist of one or more nodules in a few or many glomeruli. Nodule is an ovoid or spherical, laminated, hyaline, acellular mass located within a lobule of the glomerulus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nodules are surrounded peripherally by glomerular capillary loops which may have normal or thickened GBM. The nodules <strong>are PAS-positive and contain lipid and fibrin. </strong>These nodular lesions are frequently accompanied by prominent accumulations of hyaline material in capillary loops (\u201c<strong>fibrin caps</strong>\u201d) or adherent to Bowman's capsules (\u201c<strong>capsular drops</strong>\u201d).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/32.jpg\" alt=\"\" width=\"677\" height=\"313\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the nodular lesions enlarge, <strong>they compress the glomerular capillaries</strong> and obliterate the glomerular tuft. As a result of glomerular and arteriolar involvement, <strong>renal ischemia</strong> occurs leading to tubular atrophy and interstitial fibrosis and <strong>grossly small, contracted kidney</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Renal failure is the second common cause of death in diabetes mellitus, the first being myocardial infarction.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic nephropathy encompasses 4 types of renal lesions in diabetes mellitus:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Diabetic glomerulosclerosis (Diffuse/ Nodular)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Diffuse lesions</strong> are characterized by diffuse involvement of the glomeruli showing thickening of the GBM and diffuse increase in the mesangial matrix with mild proliferation of mesangial cells and exudative lesions (fibrin caps and capsular drops)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nodular lesion (Kimmelstiel-Wilson Lesion)&nbsp;</strong>is characterized by one or more hyaline nodules within the lobules of glomeruli, surrounded peripherally by glomerular capillaries with thickened walls.</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/33.jpg\" alt=\"\" width=\"619\" height=\"460\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2.&nbsp; Vascular lesions \u2013 <strong>Hyaline arterioslerosis</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Morphology</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/34.jpg\" alt=\"\" width=\"635\" height=\"283\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. Diabetic pyelonephritis \u2013 <strong>Papillary necrosis</strong> / Necrotizing papillitis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Tubular lesions (Armanni-Ebstein lesions</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/41.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Renal amyloidosis:</strong> Amyloidosis presents with amyloid deposits, typically visualized using Congo red stain, which is different from the PAS-positive nodules seen in Kimmelstiel-Wilson disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Focal segmental glomerulosclerosis (FSGS):</strong> FSGS is characterized by segmental scarring of some glomeruli and does not present with the diffuse nodular glomerulosclerosis observed in Kimmelstiel-Wilson disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Lupus nephritis:</strong> Lupus nephritis involves immune complex deposition, which leads to a different set of histological changes, including \"wire loop\" lesions, which are not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kimmelstiel-Wilson disease, a specific form of diabetic nephropathy, is characterized by PAS-positive nodules within the glomeruli, often associated with type 1 diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 2206</strong></span></p>",
    "correct_choice_id": 39812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Pathology-2)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>